Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Cancer of Ovary

fluorodeoxyglucose f18 has been researched along with Cancer of Ovary in 360 studies

Research

Studies (360)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	17 (4.72)	18.2507
2000's	113 (31.39)	29.6817
2010's	171 (47.50)	24.3611
2020's	59 (16.39)	2.80

Authors

Authors	Studies
Hu, XY; Li, L; Luo, NN; Peng, LH; Qiu, DS	1
Bang, JI; Choi, MC; Jang, SJ; Kim, JY; Lee, HY	1
Karanth, SS; Khanna, G; Malik, D; Manda, D; Raina, V; Sen, IB	1
Chotipanich, C; Kiatkittikul, P; Kunawudhi, A; Promteangtrong, C; Siripongsatian, D	1
Chung, YS; Kang, WJ; Kim, HS; Kim, S; Kim, SW; Kim, Y; Lee, JY	1
Kuang, A; Shen, G	2
Albano, D; Bertagna, F; Dondi, F; Giubbini, R	1
Jing, X; Li, Y; Liu, L; Pang, H; Wang, J	1
Dzul, S; Joiner, M; Miller, SR; Musa, A	1
Chen, Y; Feng, Y; Liu, L; Wang, L; Zheng, W	1
Liu, W; Ou, X; Yao, X	1
Cheon, GJ; Cho, YS; Gil, J; Hwangbo, S; Kim, J; Kim, JW; Kim, SI; Lee, JW; Lee, M; Noh, JJ	1
Feng, Z; Ge, H; Ju, X; Liu, S; Song, S; Wu, X; Xu, X	1
Cheng, W; Huo, L; Liu, M; Wang, P	1
Baiocchi, G; da Costa, AABA; Diniz, TP; Faloppa, CC; Mantoan, H; Nunes, RL; Teixeira, FR	1
Cheng, J; Lin, L; Liu, Q; Song, M; Wang, T; Zhou, B; Zhou, Y	1
Sun, G; Yao, L; Zou, R; Zuo, C	1
Choi, MC; Jang, SJ; Kim, T; Lee, JW; Lee, SM	1
Hou, G; Jin, Y; Peng, P; Zheng, R	1
Wang, X; Xue, B	1
Chen, C; Guo, P; Li, X; Sun, Q; Wang, L; Zhang, Y	1
Fijuth, J; Foks, M; Gottwald, L; Kalita, K; Kosinska, M; Kuncman, L; Misiewicz, P	1
Lyburn, I; Nawwar, A; Robinson, E; Searle, J	1
Hildebrandt, MG; Jensen, PT; Mogensen, O; Sponholtz, SE	1
Chen, Y; Huang, Z; Sun, R	1
Hamanaka, Y; Hamanishi, J; Ishimori, T; Kido, A; Nakamoto, Y; Saga, T; Togashi, K; Watanabe, M	1
Han, SS; Kim, MK; Ko, A; Lee, ES; Park, HJ; Park, SB; Seok, JW	1
Liu, S; Wu, X; Xiang, L; Yang, H; Ye, S; Zhou, S	1
Cheng, X; Hou, G; Jiang, Y	1
Cheng, X; Hou, G; Jiang, Y; Li, F	1
Cheng, W; Hou, G; Jiang, Y; Wu, F; Zhang, W; Zhu, Z	1
Orta, N; Repetto, A; Rubí, S	1
Koyasu, S; Minamiguchi, S; Nakamoto, Y; Otani, T; Togashi, K	1
Chung, YS; Kang, WJ; Kim, HS; Kim, S; Kim, SW; Kim, YT; Lee, JY; Nam, EJ	1
Bendifallah, S; Body, G; Bricou, A; Collinet, P; Delvallée, J; Huchon, C; Lavoue, V; Ouldamer, L; Rossard, L; Touboul, C	1
Khalil, FK; Mohamed, AZ; Tanvetyanon, T; Toloza, EM	1
Cui, XW; Gu, L; Li, YS; Sun, J; Wang, SY; Wang, XN; Yin, Q	1
Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y	1
Cheng, W; Cheng, X; Hou, G; Jiang, Y; Zhu, Z	1
Dai, W; Feng, Y; Pu, Q; Wang, P	1
Kang, S; Kim, SK; Kim, TS; Lim, MC; Park, S; Park, SY; Seo, SS; Yoo, CW	1
Bhosale, P; Ganeshan, D; Gulati, AT; Iyer, R; Palmquist, S; Virarkar, M	1
Bozec, L; Champion, L; Nascimento-Leite, C; Seban, RD	1
Aide, N; Alexandre, J; Berton, D; Bonichon, N; Combe, P; Coquan, E; De Rauglaudre, G; Fauchille, P; Ferron, G; Joly, F; Leary, A; Meunier, J; Pujade Lauraine, E	1
Ghosh, I; Khan, EM; Sharma, P	1
Bektaş, S; Beyhan, E; Çermik, TF; Ergül, N; Erol, Ö	1
Erdil, TY; Filizoglu, N; Kesim, S; Ones, T; Ozguven, S	1
Asano, R; Matsuura, T; Miyasaka, N; Otsuka, I; Ouchi, E; Ouchi, T	1
Andersen, G; Blaakaer, J; Bouchelouche, K; Iversen, LH; Marinovskij, E; Mikkelsen, MS; Petersen, LK; Rosenkilde, M	1
Cosio, S; Depalo, T; Gadducci, A; Giorgetti, A; Guidoccio, F; Manca, G; Miccoli, M; Simonetti, E; Volterrani, D	1
Ahlström, H; Bergman, A; Jónsdóttir, B; Poromaa, IS; Ripoll, MA; Silins, I; Stålberg, K	1
Barriere, J; Bondouy, M	1
Dabiri, BE; Jacene, HA	1
Chang, CW; Chang, MC; Chen, YA; Chiu, SJ; Jeng, FS; Ke, CC; Li, JJ; Lin, SL; Liu, RS; Lu, CH; Yang, BH	1
Shi, H; Yin, H	1
Chantalat, E; Ferron, G; Gabiache, E; Martinez, A; Zerdoud, S	1
Angeles, MA; Barranger, E; Betrian, S; Cabarrou, B; Chantalat, E; Chardin, D; Ducassou, A; Ferron, G; Frigenza, M; Gabiache, E; Mallet, E; Martinez, A; Martínez-Gómez, C; Motton, S; Navarro, AS; Tanguy Le Gac, Y; Viau, P	1
Calapaquí Terán, AK; Delgado Bolton, RC; Ferrero, A; Giammarile, F; Pellet, O	1
Dharmendra, S; Kumar, R; Kumari, A; Sachani, H; Sharma, JB; Singh, U	1
Capacchione, D; Gallicchio, R; Guglielmi, G; Mainenti, P; Nardelli, A; Pedicini, P; Pelagalli, A; Sirignano, C; Storto, G; Venetucci, A	1
Narayanan, P; Sahdev, A	1
Kim, CK; Zukotynski, KA	1
Amit, A; Hodes, A; Keidar, Z; Lavie, O; Lowenstein, L; Matanes, E	1
Jiang, C; Jiang, S; Lyu, W; Ma, X; Wang, M; Xia, F; Zhang, Y	1
Fujiwara, S; Nishimura, T; Takahashi, N; Tsuyoshi, H; Yoshida, Y	1
Jung, PS; Kim, JK; Kim, YM; Kim, YT; Lee, JJ; Lee, YJ; Nam, JH	1
Chondrogiannis, S; Marzola, MC; Rubello, D	1
Grigsby, PW; Rao, YJ	1
Cheng, J; Ou, X; Ye, Y	1
Chen, X; Feng, Z; Ju, X; Liu, S; Wen, H; Wu, X; Xu, J	1
An, H; Chang, C; Chiu, K; Lee, EYP	1
Aranda Aguilar, E; Cordero García, JM; García Vicente, AM; Jiménez Londoño, GA; Palomar Muñoz, A; Pena Pardo, FJ; Soriano Castrejón, Á; Talavera Rubio, MDP	1
Chen, X; Deng, Y; Feng, Z; Jiang, Z; Ju, X; Liu, S; Pan, H; Wen, H; Wu, X; Xu, J; Zhang, L	1
Alavi, A; Gjedde, A; Høilund-Carlsen, PF; Johnsen, IBG; Neumann, G; Olsen, BB; Torigian, DA; Vilstrup, MH	1
Cheng, J; Feng, Z; Liu, S; Lu, L; Sun, Y; Wang, M; Xu, J; Yuan, H; Zhang, Y	1
Date, H; Hamaji, M; Koyasu, S; Yamaguchi, K	1
Han, S; Kim, H; Kim, YJ; Suh, CH; Woo, S	1
Colletti, PM; Marzola, MC; Rubello, D	2
Han, S; Lee, JJ; Suh, CH; Woo, S	1
Hoogendam, JP; Roze, JF; Scholten, RJ; Spijker, R; van de Wetering, FT; Veldhuis, WB; Verleye, L; Vlayen, J; Zweemer, RP	1
Matsutani, H; Nakai, G; Narumi, Y; Ohmichi, M; Yamada, T; Yamamoto, K	1
Chong, GO; Han, HS; Hong, DG; Jeong, SY; Lee, HJ; Lee, SW; Lee, YH; Lee, YS	1
Colinas, D; Fra, J; García-Talavera, P; Montes, A; Tamayo, P	1
Liu, S; Wu, X; Xiang, L; Yang, H; Ye, S	1
Amorim, BJ; Bernardo, WM; Brito, AET; Esteves, FP; Gomes, GDV; Martello, M; Matushita, CS	1
Auranen, A; Grénman, S; Hietanen, S; Hynninen, J; Kemppainen, J; Laasik, M; Seppänen, M	1
Dong, A; Wang, Y; Zuo, C	1
Björkling, F; Erichsen, KD; Højgaard, L; Jensen, MM; Jensen, PB; Johnbeck, CB; Kjær, A; Madsen, J; Sehested, M	1
Dunne, RM; McDermott, R; O'Keeffe, SA; O'Mahony, D; Wilson, G	1
An, YS; Jo, KS; Lee, DH; Lee, SJ; Yoon, JK; Yoon, SH	1
Iwanaka, T; Kanamori, Y; Momose, T; Takahashi, M	1
Cao, G; Lan, X; Liao, S; Yuan, H; Zhang, Y	1
Takei, T; Uchiyama, M	1
Kumagai, K; Ohmichi, M; Okamura, T; Senzaki, H; Toyoda, M; Watanabe, C	1
Buda, A; Ceppi, L; Crivellaro, C; Cuzzucrea, M; Elisei, F; Fruscio, R; Guerra, L; Messa, C; Pirovano, C; Signorelli, M	1
Amant, F; Berteloot, P; Dauwen, H; Deroose, CM; Leunen, K; Neven, P; Op de Beeck, K; Timmerman, D; Van Calster, B; Vergote, I	1
Auranen, A; Carpén, O; Grénman, S; Hynninen, J; Kemppainen, J; Lavonius, M; Matomäki, J; Oksa, S; Seppänen, M; Virtanen, J	1
Crivellaro, C; Cuzzocrea, M; Dell'Anna, T; Dolci, C; Fruscio, R; Guerra, L; Messa, C; Milani, R; Signorelli, M; Sina, F	1
Adamiak, P; Czepczyński, R; Fularz, M; Jarzabek-Bielecka, G; Kedzia, W; Ruchała, M	1
Ebina, Y; Hosaka, M; Kaneuchi, M; Kudo, M; Sakuragi, N; Takeda, M; Watari, H; Yamada, H	1
Chen, T; Chen, YM; Shi, YP; Tong, LJ; Wan, LR; Zee, CS	1
Kim, DY; Kim, JH; Kim, YM; Kim, YT; Lee, JJ; Lee, SW; Nam, JH; Park, JY; Seo, MJ; Shim, SH	1
Horikawa, M; Kaji, T; Miyai, K; Shinmoto, H; Soga, S	1
Amant, F; De Keyzer, F; Deroose, C; Dymarkowski, S; Leunen, K; Michielsen, K; Moerman, P; Op de Beeck, K; Souverijns, G; Vandecaveye, V; Vergote, I	1
Bauerschlag, DO; Behrendt, FF; Hebel, CB; Heinzel, A; Krohn, T; Mottaghy, FM; Verburg, FA	1
Bottoni, C; Chiantera, V; Costantini, B; Fagotti, A; Fanfani, F; Gallotta, V; Petrillo, M; Scambia, G; Turco, LC	1
Björkling, F; Erichsen, KD; Højgaard, L; Jensen, PB; Kjær, A; Madsen, J; Munk Jensen, M; Sehested, M	1
Ino, K; Kobayashi, A; Mabuchi, Y; Minami, S; Ota, N; Shiro, M; Takano, R; Tanizaki, Y; Terada, M; Yagi, S	1
Hong, JH; Kim, S; Lee, JK; Min, KJ; So, KA	1
Coleman, RL; Gershenson, DM; Lucchini, M; Macapinlac, HA; Munsell, MF; Ramirez, PT; Schmeler, KM; Takeuchi, S	1
Chondrogiannis, S; Colletti, PM; Fagioli, G; Grassetto, G; Maffione, AM; Marzola, MC; Musto, A; Perkins, AC; Rampin, L; Rubello, D	1
Avril, N; Bergstrom, D; Brenton, JD; Iannone, R; Lam, R; McNeish, IA; Mozley, PD; Parkinson, C; Rockall, AG; Sala, E; Sarker, SJ	1
Boers-Sonderen, MJ; de Geus-Oei, LF; Desar, IM; Ottevanger, PB; Oyen, WJ; van der Graaf, WT; van Herpen, CM	1
Hatazawa, J; Hori, M; Hori, Y; Kim, T; Morii, E; Nakamoto, A; Onishi, H; Sakane, M; Tatsumi, M; Tomiyama, N; Tsuboyama, T	1
Cho, A; Kang, WJ; Kim, YT; Lee, JD; Lee, JH; Lee, JW; Yun, M	2
Brendle, C; Claussen, CD; Gatidis, S; Königsrainer, I; Müller, M; Pfannenberg, AC; Schmidt, H; Schraml, C; Schwenzer, NF	1
Kojima, A; Konishi, H; Nogawa, T; Okame, S; Shiroyama, Y; Sugawara, Y; Takehara, K; Yamamoto, Y; Yokoyama, T	1
Beiderwellen, K; Forsting, M; Gratz, M; Grueneisen, J; Heubner, M; Heusch, P; Kinner, S; Lauenstein, T; Ruhlmann, V; Schulze-Hagen, A; Umutlu, L	1
Garcheva, M; Gocheva, L; Zlatareva, D	1
Aktas, B; Beiderwellen, K; Buderath, P; Forsting, M; Grueneisen, J; Heusch, P; Kraff, O; Lauenstein, TC; Ruhlmann, V; Umutlu, L	1
Kanda, M; Ohara, N; Sonoyama, A	1
Kim, DY; Kim, JH; Kim, SN; Kim, SO; Kim, YM; Kim, YT; Lee, JJ; Lee, SJ; Nam, JH; Shim, SH	1
Basu, S; Rachh, S; Ranade, R	1
Ahn, BC; Chong, GO; Jeong, SY; Jung, JH; Kim, CY; Kim, DH; Lee, J; Lee, SW; Son, SH	1
Catalano, OA; Dehdashti, F; Lee, SI	1
Espeli, V; Giovanella, L; Treglia, G	1
Nogawa, T; Okame, S; Shiroyama, Y; Sugawara, Y; Takehara, K; Yamamoto, Y; Yokoyama, T	1
Marangmei, C; Sharma, P	1
Burdan, F; Janczarek, M; Mocarska, A; Starosławska, E; Walczewska, M; Żelazowska-Cieślińska, I	1
Borbély, K	1
Achtari, C; Meuli, RA; Prior, JO; Schmidt, S	1
Burger, IA; Chi, DS; Goldman, DA; Hricak, H; Miccò, M; Sala, E; Sosa, RE; Vargas, HA; Weber, W	1
Han, EJ; Kim, SH; O, JH; Park, HL; Yoo, IeR	1
Cao, DY; Peng, P; Shen, K; Yang, JX; Zheng, K; Zhong, ZJ; Zhu, ZH	1
Adamiak, P; Czepczyński, R; Fularz, M; Jarząbek-Bielecka, G; Kędzia, W; Rewers, A; Ruchała, M	1
Brunetti, JC	1
Alongi, P; Caobelli, F; Castello, A; Cocciolillo, F; Crivellaro, C; De Biasi, V; Dolci, C; Evangelista, L; Geatti, O; Kirienko, M; Laghai, I; Picchio, M; Popescu, CE; Quartuccio, N; Rensi, M; Saladini, G; Seghezzi, S	1
Agarwal Sharma, R; Khong, PL; Lee, EY; Ngu, SF; Vardhanabhuti, V	1
Auranen, A; Carpén, O; Grénman, S; Hynninen, J; Kemppainen, J; Matomäki, J; Oksa, S; Peter, A; Roering, P; Seppänen, M; Vallius, T	1
Agarwal, KK; Kumar, R; Roy, SG	1
Abdelhafez, YG; El Refaei, S; Hamada, E; Osama, A; Tawakol, A	1
Chino, Y; Fujita, Y; Kiyono, Y; Kurokawa, T; Okazawa, H; Tsujikawa, T; Yamamoto, M; Yoshida, Y	1
Fallanca, F; Gianolli, L; Incerti, E; Mapelli, P; Picchio, M	1
Han, YH; Jeong, HJ; Kim, J; Lim, ST; Moon, EH; Sohn, MH	1
Bacanovic, S; Burger, IA; Huellner, MW; Pircher, M; Stiller, R	1
Arts, HJ; Broekman, KE; Brouwers, AH; de Vries, EG; Glaudemans, AW; Jalving, M; Reyners, AK; van der Zee, AG	1
Choi, WH; Han, EJ; Kim, SH; Lee, YS; Park, EK; Park, HL; Song, MJ; Yoo, IR	1
Demirag, G; Kefeli, M; Kemal, Y; Kokcu, A; Kurtoglu, E; Tosun, FC; Yucel, I	1
Beer, R; Grams, A; Hegen, H; Helbok, R; Pfausler, B; Ramberger, M; Schmutzhard, E; Uprimny, C; Virgolini, I	1
Yoon, SN	1
Bélissant Benesty, O; Cassou-Mounat, T; Montravers, F; Talbot, JN; Vatier, C	1
Andrade, RJ; Cascales-Campos, PA; Feliciangeli, E; Frutos, L; Fuster-Quiñonero, M; Gil, E; Gil, J; Lopez-Lopez, V; Parrilla, P	1
Colletti, PM; Dubreuil, J; Giammarile, F; Glehen, O; Rousset, P; Rubello, D; Skanjeti, A	1
Fushimi, Y; Ishimori, T; Nakamoto, R; Nakamoto, Y; Togashi, K	1
Bono, Y; Fujiwara, H; Iwadare, J; Mizumoto, Y; Nakamura, M; Obata, T	1
Chen, Y; Huang, Z; Liu, L; Zhu, Y	1
Fukuda, Y; Hori, Y; Kato, H; Kimura, T; Mimura, K; Tomimatsu, T; Tsuboyama, T; Yoshino, K	1
Adachi, K; Arimoto, T; Eguchi, S; Fujii, T; Fujikawa, T; Fujimoto, A; Inoue, T; Kawana, K; Nagamatsu, T; Nakamura, H; Nishida, H; Oda, K; Ogishima, J; Osuga, Y; Sato, M; Taguchi, A; Tomio, K; Wada-Hiraike, O; Yamashita, A; Yoshida, M	1
Auranen, A; Grènman, S; Hynninen, J; Matomäki, J; Oksa, S; Roering, P; Vallius, T	1
Cohn, DE; Farrar, WB; Hall, NC; Martin, EW; Povoski, SP; Seamon, LG	1
Fukasawa, I; Inaba, N; Kaji, Y; Kitajima, K; Murakami, K; Sugimura, K; Yamasaki, E	1
Lucignani, G	1
De Gaetano, AM; Fagotti, A; Fanfani, F; Giordano, A; Lorusso, D; Rossitto, C; Scambia, G; Vizzielli, G	1
Hyun, IY; Kim, SG	1
Gambhir, SS; Iagaru, AH; McDougall, IR; Mittra, ES; Quon, A	1
Baldey, A; Carter, J; Fulham, MJ; Gibson, M; Hicks, RJ; Ramshaw, JE	1
Hu, M; Kong, L; Li, MH; Liu, NB; Yang, GR; Yu, JM	1
Liu, Y	1
Mende, KA; Ramach, C; Schwarz, EI; Strobel, K	1
Bisi, G; Castellano, G; Deandreis, D; Penna, D; Varetto, T	1
Dehdashti, F; Delbeke, D; Grigsby, PW; Schwarz, JK	1
Cao, Q; Chen, X; Li, Z; Niu, G	1
Berthelsen, AK; Engelholm, SA; Høgdall, C; Høgdall, E; Jensen, F; Loft, A; Markova, E; Risum, S; Roed, H	1
Bellomi, M; Bonello, L; Funicelli, L; Landoni, F; Travaini, LL; Trifirò, G	1
Brooks, RA; Powell, MA	1
Hiyama, A; Kawakami, Y; Kusano, T; Nawata, S; Suga, K	1
Huang, YT; Kumar, AS; Lee, JC	1
Jung, YW; Kim, JH; Kim, JW; Kim, S; Kim, SW; Kim, YT; Nam, EJ; Oh, YT; Yun, MJ	1
Grahek, D; Hassan-Sebbag, N	1
Jaaback, K; Proietto, A; Raj, G	1
Berthelsen, AK; Engelholm, SA; Høgdall, C; Høgdall, E; Loft, A; Lundvall, L; Nedergaard, L; Risum, S	5
Castiglione, F; Molino, C; Olivieri, S; Susini, T; Tavella, K; Viligiardi, R	1
Iyer, VR; Lee, SI	1
Enomoto, T; Hatazawa, J; Higuchi, I; Imaizumi, M; Inoue, A; Isohashi, K; Kato, H; Kimura, T; Nakajo, K; Shimosegawa, E; Tatsumi, M	1
Chen, YK; Huang, LW; Lee, SL; Pan, HS	1
Bilici, A; Canpolat, N; Gumus, M; Salepci, T; Seker, M; Tekinsoy, B; Ustaalioglu, BB	1
Armstrong, AY; Hill, M; McCarthy-Keith, DM; McKeeby, J; Millo, C; Norian, JM	1
Fotopoulos, A; Kyritsis, AP; Sioka, C	1
Blake, MA; Cronin, CG; Prakash, P	1
Arellano, RS; Flanders, VL; Gervais, DA; Lee, SI; Mueller, PR	1
Abe, W; Narahara, H; Nasu, K; Takai, N; Tomonari, K	1
Even-Sapir, E; Inbar, M	1
Bhosale, P; Iyer, RB; Levenback, CF; Macapinlac, HA; Peungjesada, S; Rohren, E; Schmeler, K; Wei, W	1
Al-Nahhas, A; Allegri, V; Cacciari, N; De Iaco, P; Fanti, S; Musto, A; Orazi, L; Rosati, M; Rubello, D; Venturoli, S; Zamagni, C	1
Celi, FS; Cochran, CS; Davis, JL; Hughes, M; Merino, MJ; Reynolds, JC; Wolff, EF	1
Fodor, Z; Galuska, L; Goda, K; Hernádi, Z; Krasznai, ZT; Mikecz, P; Szabó, G; Tóth, A	1
Björkling, F; Erichsen, KD; Højgaard, L; Jensen, MM; Jensen, PB; Kjær, A; Madsen, J; Sehested, M	1
Di Donato, V; Giorgini, M; Manci, N; Marchetti, C; Panici, PB; Tesei, J	1
Komatsu, Y; Maekawa, H; Orita, H; Sakurada, M; Sato, K	1
Bernardi, A; Castellucci, P; D'Errico Grigioni, A; De Iaco, P; Fanti, S; Lopci, E; Martoni, AA; Musto, A; Quercia, S; Ricci Maccarini, L; Rosati, M; Zamagni, C	1
Kaji, Y; Kitajima, K; Murakami, K; Sakamoto, S; Sugimura, K	1
Al-Nahhas, A; Allegri, V; Ambrosini, V; Castellucci, P; Fanti, S; Grassetto, G; Montini, GC; Nanni, C; Palomar, A; Pettinato, C; Rubello, D; Soriano, A	1
Kita, M; Kitajima, K; Maeda, T; Ohno, Y; Onishi, Y; Senda, M; Sugimura, K; Suzuki, K; Yoshikawa, T	1
Buecher, B; Deleau, C; des Varannes, SB; Flamant, M; Frampas, E; Galmiche, JP; Kraeber-Bodéré, F; Matysiak-Budnik, T; Rousseau, C	1
Choi, I; Lee, HJ; Nam, KT; Peterson, TE; Price, RR; Tantawy, MN	1
Avril, N; Gourtsoyianni, S; Reznek, R	1
Kita, M; Kitajima, K; Maeda, T; Nakamoto, Y; Ohno, Y; Onishi, Y; Senda, M; Sugimura, K; Suzuki, K; Yoshikawa, T	1
Kato, H; Kikawa, S; Minobe, S; Sakuragi, N; Todo, Y; Yamashiro, K	1
Hu, C; Liou, WS; Liu, CB; Liu, RS; Peng, NJ; Tsay, DG	1
Chen, YW; Hou, MF; Hou, PN; Lee, CS; Lin, CY; Tsai, EM	1
Hong, JH; Kim, SE; Lee, JK; Lee, KW; Lee, NW; Song, SH	1
Andreou, J; Efthimiadou, R; Gogou, L; Laspas, F; Prassopoulos, V; Vlachou, F	1
Ho, L; Kaushik, A; Wassef, H; Zhang, W	1
Al-Nahhas, A; Castellucci, P; Fanti, S; Fuccio, C; Marzola, MC; Rubello, D	1
Hu, SL; Zhang, YJ; Zhou, ZR	1
Kaji, Y; Kita, M; Kitajima, K; Maeda, T; Murakami, K; Sugimura, K; Suzuki, K; Ueno, Y	1
Celik, Y; Erdemoğlu, M; Guzel, AI; Komek, H; Kuyumcuoğlu, U	1
Hu, C; Peng, NJ; Su, HM; Tsay, DG	1
Bats, AS; Bensaid, C; Faraggi, M; Huchon, C; Hugonnet, F; Lécuru, F; Pierquet-Ghazzar, N	1
Chung, HH; Chung, JK; Kang, KW; Kang, SB; Kim, JW; Kwon, HW; Park, NH; Song, YS	1
Al-Nahhas, A; Grassetto, G; Groheux, D; Hindié, E; Marzola, MC; Rubello, D	1
Allen-Auerbach, M; Czernin, J; Karantanis, D	1
Bakir, B; Has, D; Iyibozkurt, C; Mudun, A; Ozel, S; Sanli, Y; Topuz, S; Turkmen, C; Unal, SN; Yavuz, E; Yilmaz, E	1
Hiramatsu, Y; Hongo, A; Kodama, J; Nakamura, K	1
Basu, S; Kand, P; Kumar Dhingra, V	1
Henderson, R; Ho, L; Nakla, A; Wassef, H	1
Aboagye, EO; Gabra, H; Perumal, M; Stronach, EA	1
Atkinson, E; Bast, RC; Coleman, RL; Coombes, KR; Dice, K; Dyer, M; Fu, S; Gershenson, DM; Hennessy, BT; Howard, A; Jackson, E; Ju, Z; Kavanagh, JJ; Kundra, V; Kurzrock, R; Levenback, CF; Li, J; Li, Y; Markman, M; Mills, GB; Ng, CS; Sood, AK; Stemke-Hale, K; Wolf, JK	1
Han, A; Hu, M; Wang, X; Xue, J; Zheng, J	1
Ebina, Y; Kita, M; Kitajima, K; Maeda, T; Senda, M; Sugimura, K; Suzuki, K; Ueno, Y; Yamada, H	1
Auranen, A; Carpén, O; Dean, K; Grénman, S; Hynninen, J; Kemppainen, J; Lavonius, M; Lisinen, I; Seppänen, M; Virtanen, J	1
Bochev, P; Bocheva, Y; Chaushev, B; Dancheva, J; Ivanov, S; Klisarova, A	1
Apperloo, MJ; Balink, H; Collins, J	1
Antunovic, L; Balestreri, L; Baresic, T; Borsatti, E; Canzonieri, V; Cecchin, D; Cimitan, M; Giorda, G; Pepe, G; Rubello, D; Sorio, R; Steffan, A; Tatta, R	1
Lee, H; Lee, HJ; Luci, JJ; Nam, KT; Peterson, TE; Price, RR; Tantawy, MN	1
Avril, N; Munari, A; Rockall, A	1
Kamali, G; Mulazimoglu, M; Ozcan, D; Ozpacaci, T; Tamam, MO	1
Eker, O; Kamali, G; Mulazimoglu, M; Ozpacaci, T; Tamam, MO	1
Altini, C; Giganti, M; Merenda, N; Niccoli Asabella, A; Notaristefano, A; Rubini, D; Rubini, G; Stabile Ianora, AA	1
Blake, MA; Cronin, CG; McDermott, S; O'Connor, OJ; Prakash, P	1
Björkling, F; Bzorek, M; Erichsen, KD; Højgaard, L; Jensen, MM; Jensen, PB; Johnbeck, CB; Kjær, A; Madsen, J; Sehested, M	1
Eid, H; El-Gammal, M; Murakami, K; Zytoon, AA	1
Ahn, BC; Gayed, IW; Kim, HW; Won, KS; Zeon, SK	1
Bhattacharya, A; Jain, V; Kumar, R; Mittal, BR; Nijhawan, R; Raveendran, A; Santhosh, S; Sharma, SC	1
Bombardieri, E; Crippa, F; Pauwels, EK; Stokkel, MP; Ugrinska, A	1
Biersack, HJ; Matthies, A; Reinhardt, MJ	1
Huang, H; Lang, J; Pan, L; Shen, K; Wu, M; Zhu, X	1
Byun, JY; Cho, SM; Ha, HK; Kim, CJ; Lee, JM; Nam-Koong, SE	1
Cabrera Villegas, A; Gámez Cenzano, C; García Velloso, MJ	1
Chang, WC; Hung, YC; Kao, CH; Lin, CC; Shen, YY; Yen, RF	1
Fujibayashi, Y; Kawahara, K; Kotsuji, F; Kurokawa, T; Tsuchida, T; Yonekura, Y; Yoshida, Y	1
Kawabe, J; Koyama, K; Miyama, M; Ochi, H; Okamura, T; Ozawa, N; Torii, K; Umesaki, N; Yamada, R	1
Futatsubashi, M; Kanno, T; Maeda, M; Nakamura, F; Okada, H; Ouchi, Y; Takekuma, M; Torizuka, T; Yoshikawa, E	1
Drieskens, O; Gysen, M; Mortelmans, L; Stroobants, S; Vandenbosch, G; Vergote, I	1
Aletti, G; De Cobelli, F; De Marzi, P; Del Maschio, A; Fazio, F; Ferrari, A; Gianolli, L; Landoni, C; Mangili, G; Messa, C; Picchio, M; Sironi, S; Viganò, R; Zangheri, B	1
Larson, SM; Macapinlac, HA; Salmon, AS; Turlakow, A; Yeung, HW	1
Fujibayashi, Y; Kawahara, K; Kotsuji, F; Kurokawa, T; Okazawa, H; Tsuchida, T; Yonekura, Y; Yoshida, Y	2
Even-Sapir, E; Fishman, A; Grisaru, D; Lerman, H; Lievshitz, G; Metser, U	1
Henley, T; Lilien, DL; Ramaswamy, MR; Reddy, MP	1
Daraï, E; Dormont, D; Madelenat, P; Zylberberg, B	1
Huglo, D; Vinatier, D	1
Chung, JK; Jeong, JM; Kang, SB; Kim, MH; Kim, S; Lee, DS; Lee, MC	1
Cesnik, R; Frühwald, F; Leitha, T; Steiner, E	1
Helmberger, T; Linke, R; Schroeder, M; Voltz, R	1
Döbert, N; Grünwald, F; Hamscho, N; Matic, V; Menzel, C; Vasvatekis, S; Wördehoff, N; Zaplatnikov, K	1
Bouhnik, JP; Even-Sapir, E; Lerman, H; Levin, C; Lievshitz, G; Miller, E; Yuzefovich, B; Zak, O	1
Barranger, E; Cortez, A; Daraï, E; David-Montefiore, E; Kerrou, K; Petegnief, Y	1
MacApinlac, HA; Martínez-Román, S; Oh, J; Ramirez, PT; Viciedo, MG	1
Kang, KW; Kim, SK; Lee, ES; Park, SY; Roh, JW; Sim, JS	1
Havrilesky, LJ; Kulasingam, SL; Matchar, DB; Myers, ER	1
Berr, F; Caca, K; Kluge, R; Mössner, J; Müller, D; Sabri, O; Wiedmann, M	1
De Iaco, P; Erba, P; Fanti, S; Farsad, M; Mariani, G; Nanni, C; Rampin, L; Rubello, D; Sansovini, M	1
Barranger, E; Daraï, E; Grahek, D; Talbot, JN; Uzan, S	1
Maeda, M; Ozawa, T; Takekuma, M; Torizuka, T; Yasumi, K	1
Bristow, RE; Díaz-Montes, TP; Jacene, HA; Wahl, RL	1
Chang, TC; Chen, MY; Lai, CH; Ma, SY; Ng, KK; Wu, TI	1
Avril, N; Graeff, H; Kuhn, W; Naehrig, J; Rutke, S; Sassen, S; Schmalfeldt, B; Schwaiger, M; Weber, WA; Werner, M	1
Hoskin, P; Short, S; Wong, W	1
Ances, B; Dalmau, J; Jiang, Z; Mason, W; Vitaliani, R; Zwerdling, T	1
Markman, M	2
Angioli, R; Bellati, F; Benedetti Panici, P; Graziano, M; Manci, N; Muzii, L; Pernice, M	1
Comte, F; Eberlé, MC; Lamy, PJ	1
Hany, TF; Strobel, K; Thuerl, CM	1
Mattsson, C; Sam, S; Stanhope, CR; Young, WF	1
Castellucci, P; Fanti, S; Farsad, M; Gross, MD; Mariani, G; Nanni, C; Rampin, L; Rubello, D	1
Kanenishi, K; Komoto, D; Monden, T; Nishiyama, Y; Ohkawa, M; Ohno, M; Sasakawa, Y; Satoh, K; Toyama, Y; Yamamoto, Y	1
Grahek, D; Talbot, JN	1
Bonichon, F; Bosquet, L; Bourguet, P; Corone, C; Giard-Lefèvre, S; Hitzel, A; Houvenaeghel, G; Morett, JL; Touboul, E; Vinatier, D	1
Higuchi, T; Izuta, M; Kato, Y; Kojima, R; Kurosaki, H; Maruno, H; Okazaki, A; Oriuchi, N; Tamaki, T; Uki, A	1
Bartholeyns, J; Coverdale, J; Eu, P; Hicks, RJ; Lau, E; Mileshkin, L; Prince, HM; Ritchie, D; Thompson, M; Wall, D; Wong, J	1
Cherng, SC; Chiu, CS; Fan, YM; Liou, CH; Yuan, YN	1
Byun, JY; Cho, SM; Kim, HS; Lee, BY; Lee, JM; Lee, KH; Lee, KY; Park, GS; Park, YG; Song, KS	1
Bosquet, L; Bourguet, P; Hitzel, A; Houvenaeghel, G; Vinatier, D	1
Chauhan, A; Dadparvar, S; Jana, S; Kumar, R	1
Hama, Y	1
Alberini, JL; Gontier, E; Guinebretiere, JM; Wartski, M	1
Lau, WF; Lourie, R; Taranto, AJ	1
Chung, HH; Chung, JK; Kang, SB; Kang, WJ; Kim, JW; Lee, HP; Park, NH; Song, YS	1
Goerres, GW; Paul, SA; Stoeckli, SJ; von Schulthess, GK	1
Bettinardi, V; Bornaghi, D; Crivellaro, C; Fazio, F; Mangili, G; Messa, C; Picchio, M; Rabaiotti, E; Sironi, S; Viganò, R	1
Avril, N; DeLoia, JA; Gallion, H; Thrall, MM	1
Chang, TC; Lai, CH; Yen, TC	1
Grabiec, M; Nowicki, P; Walentowicz, M	1
Brucker-Davis, F; Bständig, B; Fenichel, P; Kunstmann, L; Mouroux, J; Rigot, P	1
Aramendía, JM; Ceamanos, C; García-Velloso, MJ; Garrastachu, MP; Jurado, M; López-García, G; Richter, JA	1
Becker, JU; Bockisch, A; Haude, M; Kimmig, R; Lahner, H; Mann, K; Matuszczyk, A; Petersenn, S; Veit, P	1
Bourbouloux, E; Bridji, B; Graveleau, J; Kraeber-Bodéré, F; Lanctin-Garcia, C; Marchand, V; Resche, I; Rousseau, C	1
Bellati, F; Boni, T; Manci, N; Marchetti, C; Morano, G; Panici, PB; Pernice, M	1
Al-Nahhas, A; Castellucci, P; Fanti, S; Farsad, M; Fazio, F; Ghi, T; Meriggiola, MC; Messa, C; Nanni, C; Pelusi, G; Perrone, AM; Picchio, M; Rubello, D	1
Berdel, WE; Bremer, C; Brunnberg, U; Mesters, RM; Müller-Tidow, C; Schleicher, C; Schliemann, C; Schmidt, E; Staebler, A; Stegger, L; Thoennissen, NH	1
Tuncel, M	1
Coleman, RL; Gershenson, DM; Han, LY; Jennings, N; Kamat, AA; Kim, TJ; Kundra, V; Landen, CN; Langley, R; Lin, YG; Lu, C; Merritt, WM; Ravoori, M; Sood, AK; Spannuth, WA	1
Alberini, JL; Alexandre, J; Callet, N; Cherel, P; Fourme, E; Goupil, A; Le Stanc, E; Pecking, AP; Soussan, M; Wartski, M	1
Reinhardt, MJ	1
Chen, LY; Cheng, WF; Li, PC; Liao, AH	1
Domeki, Y; Fukasawa, I; Inaba, N; Kaji, Y; Kitajima, K; Murakami, K; Suganuma, N; Sugimura, K; Yamasaki, E	1
Fukaya, T; Kohsaki, S; Maeda, N; Oguri, H; Yamada, R; Yamamoto, Y	1
Cheng, WF; Hwang, JJ; Li, CH; Li, PC; Liao, AH	1
Ball, D; Bohdiewicz, PJ; Dworkin, H; Juni, JE	1
Brown, RS; Clavo, AC; Wahl, RL	1
Bohdiewicz, PJ; Dworkin, HJ; Fink-Bennett, D; Juni, JE; Nagle, C; Scott, GC; Wilner, F	1
Cane, P; Glaspy, J; Hawkins, R; Hoh, C; Karlan, BY; Lee, M; Tse, N	1
Buonocore, E; Gould, HR; Hubner, KF; McDonald, TW; Niethammer, JG; Smith, GT	1
Brown, RS; Fisher, SJ; Wahl, RL	1
Clavo, AC; Higashi, K; Wahl, RL	2
Clavo, AC; Wahl, RL	1
Alavi, A; Goldenberg, DM; Hanley, D; Herskovic, T; Juweid, M; Pereira, M; Rubin, AD; Sharkey, RM; Swayne, LC	1
Avril, N; Dose, J; Herz, M; Jänicke, F; Kuhn, W; Römer, W; Schwaiger, M; Ziegler, S	1
Clavo, AC; Torizuka, T; Wahl, RL	1
Arienti, F; Bogni, A; Bombardieri, E; Botti, C; Canevari, S; Crippa, F; Lombardo, C; Maffioli, L; Massaron, S; Negri, DR; Nerini-Molteni, S; Pascali, C; Ramakrishna, V; Remonti, F; Seregni, E	1
Büll, U; Cremerius, U; Rath, W; Schröder, W; Wolters, S; Zimny, M	1
Ali, A; Alibazoglu, H; LaMonica, G; Megremis, D	1
Brambs, HJ; Fenchel, S; Grab, D; Kotzerke, J; Kreienberg, R; Nüssle, K; Reske, SN; Rieber, A; Stöhr, I	1
Dörffler, W; Haller, U; Köchli, OR; Kubik-Huch, RA; Marincek, B; Seifert, B; Steinert, HC; von Schulthess, GK	1
Brambs, HJ; Fenchel, S; Flock, F; Grab, D; Kreienberg, R; Nüssle, K; Reske, SN; Rieber, A; Stöhr, I	1
Ak, I; Pauwels, EK; Stokkel, MP	1
Mechelany-Corone, C; Pecking, AP; Pichon, MF	1
Jiménez Bonilla, J; Konsvintseva, O; Maldonado Suárez, A; Martín Jorge, R; Moya García, F; Ordovás Oromendía, A; Zomeño Rodríguez, M	1
Fujii, S; Higuchi, T; Ishimori, T; Konishi, J; Mamede, M; Mandai, M; Nakamoto, Y; Saga, T; Sakahara, H; Togashi, K	1
Abdul-Karim, FW; Faulhaber, P; Miraldi, F; Rose, PG	1
Biemann, S; Buell, U; Nowak, B; Rath, W; Schröder, W; Siggelkow, W; Zimny, M	1
Chao, HT; Cho, YH; Liu, RS; Ng, HT; Wang, PH; Yuan, CC	1
Baum, RP; Przetak, C	1
Adamson, K; Begent, RH; Buscombe, JR; Green, A; Hilson, AJ; Lieberman, G; MacLean, AB; Reid, WM	1
Laking, GR; Price, PM	1
Futatsubashi, M; Kanno, T; Maeda, M; Nobezawa, S; Okada, H; Ouchi, Y; Takekuma, M; Torizuka, T; Yoshikawa, E	1
Brambs, HJ; Fenchel, S; Grab, D; Kotzerke, J; Kreienberg, R; Nuessle, K; Reske, SN; Rieber, A	1
Kangas, L; Knuutila, V; Minn, H; Paul, R; Sipilä, H	1

Reviews

57 review(s) available for fluorodeoxyglucose f18 and Cancer of Ovary

Article	Year
Diagnostic performance of noninvasive imaging using computed tomography, magnetic resonance imaging, and positron emission tomography for the detection of ovarian cancer: a meta-analysis. Annals of nuclear medicine, 2023, Volume: 37, Issue:10 Topics: Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed	2023
Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2 Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea	2022
Diagnostic performance of PET/CT and PET/MR in the management of ovarian carcinoma-a literature review. Abdominal radiology (New York), 2021, Volume: 46, Issue:6 Topics: Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography	2021
The role of The British journal of radiology, 2017, Volume: 90, Issue:1079 Topics: Adult; Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms	2017
Molecular Imaging and Precision Medicine in Uterine and Ovarian Cancers. PET clinics, 2017, Volume: 12, Issue:4 Topics: Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging, Interventional; Molecular Imaging; Neoplasm Staging; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Precision Medicine; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Neoplasms	2017
Precise preoperative diagnosis of struma ovarii with pseudo-Meigs' syndrome mimicking ovarian cancer with the combination of Journal of ovarian research, 2018, Feb-02, Volume: 11, Issue:1 Topics: Biopsy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Histocytochemistry; Humans; Iodine Radioisotopes; Meigs Syndrome; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Preoperative Care; Radionuclide Imaging; Struma Ovarii	2018
Fludeoxyglucose F 18 PET/CT Assessment of Ovarian Cancer. PET clinics, 2018, Volume: 13, Issue:2 Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Radiographic Image Enhancement; Sensitivity and Specificity	2018
The Role of PET Imaging in Gynecologic Radiation Oncology. PET clinics, 2018, Volume: 13, Issue:2 Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Middle Aged; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiation Oncology; Radiographic Image Enhancement; Sensitivity and Specificity; Uterine Cervical Neoplasms; Uterine Neoplasms; Vulvar Neoplasms	2018
The emerging roles of functional imaging in ovarian cancer with peritoneal carcinomatosis. Clinical radiology, 2018, Volume: 73, Issue:7 Topics: Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Ovary; Peritoneal Neoplasms; Peritoneum; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity	2018
Prognostic value of volume-based metabolic parameters of Annals of nuclear medicine, 2018, Volume: 32, Issue:10 Topics: Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography	2018
The Prognostic Value of 18F-FDG PET/CT in Monitoring Chemotherapy in Ovarian Cancer Both at Initial Diagnosis and at Recurrent Disease. Clinical nuclear medicine, 2018, Volume: 43, Issue:10 Topics: Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Recurrence; Treatment Outcome	2018
Performance of pre-treatment ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography for detecting metastasis in ovarian cancer: a systematic review and meta-analysis. Journal of gynecologic oncology, 2018, Volume: 29, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; MEDLINE; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed	2018
Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancer. The Cochrane database of systematic reviews, 2018, Oct-08, Volume: 10 Topics: Diffusion Magnetic Resonance Imaging; Fallopian Tube Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Neoplasm, Residual; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Tomography, X-Ray Computed	2018
Diversity of imaging features of ovarian sclerosing stromal tumors on MRI and PET-CT: a case report and literature review. Journal of ovarian research, 2018, Dec-20, Volume: 11, Issue:1 Topics: Adolescent; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2018
Relapsed ovarian cancer - diagnosis using 18F-FDG PET/CT; 4. Revista da Associacao Medica Brasileira (1992), 2019, May-02, Volume: 65, Issue:4 Topics: Brazil; Clinical Decision-Making; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity	2019
[Positron emission tomography (PET) in malignant ovarian tumors]. Ginekologia polska, 2013, Volume: 84, Issue:8 Topics: Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Ovarian Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Women's Health	2013
Management of epithelial ovarian cancer from diagnosis to restaging: an overview of the role of imaging techniques with particular regard to the contribution of 18F-FDG PET/CT. Nuclear medicine communications, 2014, Volume: 35, Issue:6 Topics: Carcinoma, Ovarian Epithelial; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2014
Late Manifestation of Struma Peritonei and Widespread Functioning Lesions in the Setting of Struma Ovarii Simulating Highly Differentiated Follicular Carcinoma. Journal of nuclear medicine technology, 2015, Volume: 43, Issue:3 Topics: Adenocarcinoma, Follicular; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Multiple Primary; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Struma Ovarii	2015
Evaluation of gynecologic cancer with MR imaging, 18F-FDG PET/CT, and PET/MR imaging. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:3 Topics: Coordination Complexes; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Recurrence, Local; Organometallic Compounds; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Salvage Therapy; Thiosemicarbazones; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Uterine Neoplasms	2015
[Diagnosis of benign ovarian lesions using imaging techniques]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2015, Volume: 38, Issue:223 Topics: Diagnosis, Differential; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Ovarian Diseases; Ovarian Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
[New trends and novel possibilities in the management of oncologic patients: clinical uses of PET/MRI]. Magyar onkologia, 2015, Volume: 59, Issue:1 Topics: Abdominal Neoplasms; Disease Management; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Medical Oncology; Multimodal Imaging; Neoplasms; Ovarian Neoplasms; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Rectal Neoplasms; Thoracic Neoplasms	2015
Fludeoxyglucose F 18 PET-Computed Tomography: Management Changes Effecting Patient Outcomes in Gynecologic Malignancies. PET clinics, 2015, Volume: 10, Issue:3 Topics: Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Neoplasms	2015
Diuretic 18F-Fluorodeoxyglucose PET/Computed Tomography in Evaluation of Genitourinary Malignancies. PET clinics, 2016, Volume: 11, Issue:1 Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms	2016
Imaging biomarkers in ovarian cancer: the role of ¹⁸F-FDG PET/CT. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2016, Volume: 60, Issue:2 Topics: Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis	2016
Molecular imaging in ovarian cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2016, Volume: 27 Suppl 1 Topics: Animals; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron-Emission Tomography; Tissue Distribution	2016
18F-FDG-PET/CT of peritoneal tumors: a pictorial essay. Nuclear medicine communications, 2017, Volume: 38, Issue:1 Topics: Carcinoma; Desmoplastic Small Round Cell Tumor; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Mesothelioma; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Pseudomyxoma Peritonei; Radiopharmaceuticals; Sarcoma; Stomach Neoplasms	2017
FDG-PET in gynaecological cancers: recent observations. European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:11 Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Ovarian Neoplasms; Positron-Emission Tomography; Radiography; Uterine Neoplasms	2008
Benign ovarian and endometrial uptake on FDG PET-CT: patterns and pitfalls. Annals of nuclear medicine, 2009, Volume: 23, Issue:2 Topics: Artifacts; Diagnosis, Differential; Endometrial Neoplasms; Endometrium; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Ovary; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed	2009
The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2009, Volume: 50 Suppl 1 Topics: Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms	2009
Novel imaging modalities in gynecologic cancer. Current oncology reports, 2009, Volume: 11, Issue:6 Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2009
[Metabolic imaging with positron-emission tomography in the advanced-stage ovarian cancers]. Bulletin du cancer, 2009, Volume: 96, Issue:12 Topics: CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals	2009
Ovarian cancer initially presenting as intramammary metastases and mimicking a primary breast carcinoma: a case report and literature review. Journal of women's health (2002), 2010, Volume: 19, Issue:1 Topics: Adult; Breast; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2010
MRI, CT, and PET/CT for ovarian cancer detection and adnexal lesion characterization. AJR. American journal of roentgenology, 2010, Volume: 194, Issue:2 Topics: Adnexal Diseases; Contrast Media; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Ovarian Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed	2010
Paraneoplastic neurological syndromes and the role of PET imaging. Oncology, 2010, Volume: 78, Issue:2 Topics: Breast Neoplasms; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Lambert-Eaton Myasthenic Syndrome; Magnetic Resonance Imaging; Ovarian Neoplasms; Paraneoplastic Syndromes; Paraneoplastic Syndromes, Nervous System; Positron-Emission Tomography; Radiopharmaceuticals; Seizures; Tomography, X-Ray Computed	2010
Role of PET/CT in ovarian cancer. AJR. American journal of roentgenology, 2010, Volume: 194, Issue:6 Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed	2010
PET in women with high risk for breast or ovarian cancer. The Lancet. Oncology, 2010, Volume: 11, Issue:9 Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Humans; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors	2010
Expression of benign and malignant thyroid tissue in ovarian teratomas and the importance of multimodal management as illustrated by a BRAF-positive follicular variant of papillary thyroid cancer. Thyroid : official journal of the American Thyroid Association, 2010, Volume: 20, Issue:9 Topics: Abdominal Pain; Adult; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Hypothyroidism; Iodine Isotopes; Lithium; Mutation; Ovarian Cysts; Ovarian Neoplasms; Proto-Oncogene Proteins B-raf; Teratoma; Thyroglobulin; Thyroid Neoplasms; Thyroxine; Treatment Outcome	2010
Limits of ¹⁸F-fluorodeoxyglucose positron emission tomography in recurrence diagnosis of borderline ovarian tumor. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2010, Volume: 20, Issue:5 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Pregnancy; Pregnancy Complications, Neoplastic; Radiopharmaceuticals; Tomography, X-Ray Computed	2010
Present and future of FDG-PET/CT in ovarian cancer. Annals of nuclear medicine, 2011, Volume: 25, Issue:3 Topics: Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome	2011
Noninvasive and invasive staging of ovarian cancer: review of the literature. Clinical nuclear medicine, 2011, Volume: 36, Issue:10 Topics: Adnexa Uteri; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2011
Spectrum of fluorodeoxyglucose-positron emission tomography/computed tomography and magnetic resonance imaging findings of ovarian tumors. Japanese journal of radiology, 2011, Volume: 29, Issue:9 Topics: Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2011
Impact of FDG-PET and -PET/CT imaging in the clinical decision-making of ovarian carcinoma: an evidence-based approach. Women's health (London, England), 2012, Volume: 8, Issue:2 Topics: Carcinoma, Ovarian Epithelial; Decision Making; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Tomography, X-Ray Computed	2012
New ways of assessing ovarian cancer response: metabolic imaging and beyond. Cancer imaging : the official publication of the International Cancer Imaging Society, 2012, Sep-28, Volume: 12 Topics: Biomarkers; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2012
PET/CT in the imaging of ovarian Cancer. Frontiers in bioscience (Elite edition), 2013, 01-01, Volume: 5, Issue:1 Topics: Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2013
Circulating tumor markers and nuclear medicine imaging modalities: breast, prostate and ovarian cancer. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 2002, Volume: 46, Issue:2 Topics: Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Ovarian Neoplasms; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals	2002
PET-imaging in tumors of the reproductive trac. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 2002, Volume: 46, Issue:2 Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Ovarian Neoplasms; Prostatic Neoplasms; Radiopharmaceuticals; Testicular Neoplasms; Tomography, Emission-Computed; Uterine Cervical Neoplasms	2002
[Positron emission tomography (PET) in clinical oncology [Part III]]. Revista espanola de medicina nuclear, 2002, Volume: 21, Issue:4 Topics: Adult; Brain Neoplasms; Breast Neoplasms; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasms; Ovarian Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed	2002
[Utilization of PET scan in breast and gynaecologic cancers]. Gynecologie, obstetrique & fertilite, 2004, Volume: 32, Issue:4 Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Ovarian Neoplasms; Tomography, Emission-Computed; Uterine Cervical Neoplasms	2004
[Role of [18F]-fluorodeoxyglucose positron emission tomography for the initial detection, staging, search for recurrences and restaging of gynaecological and breast cancers]. Gynecologie, obstetrique & fertilite, 2005, Volume: 33, Issue:6 Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Uterine Cervical Neoplasms; Uterine Neoplasms	2005
[Combined role of tumor markers and 18fluoro-deoxyglucose-positron emission tomography (18FDG-PET) in follow-up of cancer patients]. Bulletin du cancer, 2005, Volume: 92, Issue:10 Topics: Biomarkers, Tumor; Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Neoplasm Metastasis; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals	2005
How much intravenous contrast is needed in FDG-PET/CT? Nuklearmedizin. Nuclear medicine, 2005, Volume: 44 Suppl 1 Topics: Contrast Media; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Ovarian Neoplasms; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2005
Positron emission tomography in gynecological malignancies. Expert review of anticancer therapy, 2006, Volume: 6, Issue:7 Topics: Adult; Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms	2006
Positron emission tomography imaging for gynecologic malignancy. Current opinion in obstetrics & gynecology, 2007, Volume: 19, Issue:1 Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms	2007
Solitary gastric recurrence from ovarian carcinoma: a case report and literature review. Surgical oncology, 2006, Volume: 15, Issue:4 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Ovarian Neoplasms; Recurrence; Stomach Neoplasms; Tomography, Emission-Computed	2006
Gynecologic tumors. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 2008, Volume: 170 Topics: Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms	2008
Positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose in oncology. Part II. The clinical value in detecting and staging primary tumours. Journal of cancer research and clinical oncology, 2000, Volume: 126, Issue:10 Topics: Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Melanoma; Neoplasm Staging; Neoplasms; Ovarian Neoplasms; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed	2000
Evaluation of therapy response in breast and ovarian cancer patients by positron emission tomography (PET). The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 2001, Volume: 45, Issue:3 Topics: Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Ovarian Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome	2001

Trials

30 trial(s) available for fluorodeoxyglucose f18 and Cancer of Ovary

Article	Year
Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2 Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea	2022
A prospective comparison of integrated FDG-PET/contrast-enhanced CT and contrast-enhanced CT for pretreatment imaging of advanced epithelial ovarian cancer. Gynecologic oncology, 2013, Volume: 131, Issue:2 Topics: Aged; Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed	2013
Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT. European radiology, 2014, Volume: 24, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Diffusion; Diffusion Magnetic Resonance Imaging; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lymph Nodes; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult	2014
Diagnostic value of preoperative SUVmax on FDG-PET/CT for the detection of ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2014, Volume: 24, Issue:3 Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Ovary; Positron-Emission Tomography; Radiopharmaceuticals	2014
Temsirolimus and pegylated liposomal doxorubicin (PLD) combination therapy in breast, endometrial, and ovarian cancer: phase Ib results and prediction of clinical outcome with FDG-PET/CT. Targeted oncology, 2014, Volume: 9, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Polyethylene Glycols; Positron-Emission Tomography; Protein Kinase Inhibitors; Sirolimus; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Treatment Outcome; Young Adult	2014
Diagnostic performance of 18F-FDG PET/contrast-enhanced CT versus contrast-enhanced CT alone for post-treatment detection of ovarian malignancy. Nuclear medicine communications, 2016, Volume: 37, Issue:5 Topics: Adolescent; Adult; Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm, Residual; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Recurrence; Whole Body Imaging; Young Adult	2016
Postoperative human epididymis protein 4 predicts primary therapy outcome in advanced epithelial ovarian cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2017, Volume: 39, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; CA-125 Antigen; Carcinoma, Ovarian Epithelial; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Membrane Proteins; Middle Aged; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Postoperative Care; Proteins; Radiopharmaceuticals; WAP Four-Disulfide Core Domain Protein 2	2017
The impact of PET-CT in suspected recurrent ovarian cancer: A prospective multi-centre study as part of the Australian PET Data Collection Project. Gynecologic oncology, 2009, Volume: 112, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Australia; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed	2009
Influence of 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography on recurrent ovarian cancer diagnosis and on selection of patients for secondary cytoreductive surgery. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2009, Volume: 19, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography; Young Adult	2009
Diagnosis and staging of primary ovarian cancer: correlation between PET/CT, Doppler US, and CT or MRI. Gynecologic oncology, 2010, Volume: 116, Issue:3 Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed; Ultrasonography, Doppler; Young Adult	2010
Does the use of diagnostic PET/CT cause stage migration in patients with primary advanced ovarian cancer? Gynecologic oncology, 2010, Volume: 116, Issue:3 Topics: Adult; Aged; Aged, 80 and over; CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate	2010
Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer. Gynecologic oncology, 2012, Volume: 126, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Grading; Neoplasms, Glandular and Epithelial; Organoplatinum Compounds; Ovarian Neoplasms; Phosphorylcholine; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Taxoids	2012
Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET/CT scans for diagnosing ovarian cancer recurrence. European journal of radiology, 2012, Volume: 81, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Radiation Dosage; Radiation Protection; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome	2012
FDG PET/CT in staging of advanced epithelial ovarian cancer: frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread. Gynecologic oncology, 2012, Volume: 126, Issue:1 Topics: Aged; Carcinoma, Ovarian Epithelial; Diaphragm; Disease Susceptibility; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals	2012
Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Carbon Radioisotopes; Carcinoma, Squamous Cell; Carcinosarcoma; Choline; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sarcoma; Sarcoma, Clear Cell; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Neoplasms; Whole-Body Counting	2003
Advanced ovarian carcinoma: usefulness of [(18)F]FDG-PET in combination with CT for lesion detection after primary treatment. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 2003, Volume: 47, Issue:2 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome	2003
Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004, Volume: 45, Issue:2 Topics: Endometrial Neoplasms; Endometrium; Female; Fluorodeoxyglucose F18; Humans; Menstrual Cycle; Middle Aged; Ovarian Neoplasms; Ovary; Postmenopause; Premenopause; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Cervical Neoplasms	2004
[18F]FDG PET as a substitute for second-look laparotomy in patients with advanced ovarian carcinoma. European journal of nuclear medicine and molecular imaging, 2004, Volume: 31, Issue:2 Topics: Adult; Aged; Analgesics; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Korea; Laparotomy; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Second-Look Surgery; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome	2004
Coincidence imaging using 2 dual-head gamma-camera systems, with and without attenuation correction. Journal of nuclear medicine technology, 2004, Volume: 32, Issue:4 Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gamma Cameras; Gastrointestinal Neoplasms; Humans; Image Enhancement; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Melanoma; Middle Aged; Ovarian Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed	2004
(18)F-FDG PET/CT in the evaluation of recurrent ovarian cancer: a prospective study on forty-one patients. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2005, Volume: 31, Issue:7 Topics: Adult; Aged; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2005
Positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer. International journal of clinical oncology, 2005, Volume: 10, Issue:3 Topics: Adult; Aged; CA-125 Antigen; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2005
Prognostic value of FDG-PET in patients with ovarian carcinoma following surgical treatment. Annals of nuclear medicine, 2006, Volume: 20, Issue:3 Topics: Female; Fluorodeoxyglucose F18; Humans; Incidence; Japan; Longitudinal Studies; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival; Survival Rate; Treatment Outcome	2006
In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma. Cancer immunology, immunotherapy : CII, 2007, Volume: 56, Issue:2 Topics: Antibodies, Bispecific; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Indium Radioisotopes; Infusions, Intravenous; Infusions, Parenteral; Killer Cells, Lymphokine-Activated; Macrophages; Ovarian Neoplasms; Positron-Emission Tomography	2007
Role of [18F]FDG PET/CT in the assessment of suspected recurrent ovarian cancer: correlation with clinical or histological findings. European journal of nuclear medicine and molecular imaging, 2007, Volume: 34, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Population Surveillance; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed; Treatment Outcome	2007
The diagnostic value of PET/CT for primary ovarian cancer--a prospective study. Gynecologic oncology, 2007, Volume: 105, Issue:1 Topics: Adult; Aged; Aged, 80 and over; CA-125 Antigen; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed	2007
Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology. Nuclear medicine communications, 2007, Volume: 28, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Ovarian Diseases; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color	2007
Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG). Gynecologic oncology, 1993, Volume: 51, Issue:2 Topics: Adolescent; Adult; Aged; Deoxyglucose; Evaluation Studies as Topic; Female; Flow Cytometry; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Ovarian Neoplasms; Pilot Projects; Tomography, Emission-Computed	1993
Classification of asymptomatic adnexal masses by ultrasound, magnetic resonance imaging, and positron emission tomography. Gynecologic oncology, 2000, Volume: 77, Issue:3 Topics: Adnexal Diseases; Adolescent; Adult; Aged; Aged, 80 and over; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Ovarian Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed; Ultrasonography, Doppler	2000
2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer. Gynecologic oncology, 2001, Volume: 83, Issue:2 Topics: CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed	2001
Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy- D-glucose. European journal of nuclear medicine and molecular imaging, 2002, Volume: 29, Issue:6 Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; CA-125 Antigen; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Granulosa Cell Tumor; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Postoperative Care; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Whole-Body Counting	2002

Other Studies

274 other study(ies) available for fluorodeoxyglucose f18 and Cancer of Ovary

Article	Year
[(18)F-FDG PET-CT imaging of small intestinal adenocarcinoma with ovarian metastasis: two cases report]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2021, 10-23, Volume: 43, Issue:10 Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2021
Application of Multimodal Imaging Biomarker in the Differential Diagnosis of Ovarian Mass: Integration of Conventional and Molecular Imaging. Clinical nuclear medicine, 2022, Feb-01, Volume: 47, Issue:2 Topics: Biomarkers; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed	2022
18F-FDG PET/CT in Bilateral Breasts Metastasis From Ovarian Carcinoma. Clinical nuclear medicine, 2022, Feb-01, Volume: 47, Issue:2 Topics: Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography	2022
Intense 68Ga-FAPI-46 Activity in Lesions of Recurrent Ovarian Clear Cell Carcinoma That Were Negative on FDG PET/CT Study. Clinical nuclear medicine, 2022, Feb-01, Volume: 47, Issue:2 Topics: Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines	2022
Prognostic value of complete metabolic response on ¹⁸F-FDG-PET/CT after three cycles of neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer. Journal of gynecologic oncology, 2022, Volume: 33, Issue:3 Topics: Female; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies	2022
Recurrent Ovarian Cancer Presenting as a Solitary Chest Wall Metastasis Revealed by FDG PET/CT. Clinical nuclear medicine, 2022, Apr-01, Volume: 47, Issue:4 Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Thoracic Wall	2022
[18F]FDG PET/CT and CA-125 in the evaluation of ovarian cancer relapse or persistence: is there any correlation? Nuclear medicine review. Central & Eastern Europe, 2022, Volume: 25, Issue:2 Topics: CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies	2022
Preoperative PET/CT score can predict incomplete resection after debulking surgery for advanced serous ovarian cancer better than CT score, MTV, tumor markers and hematological markers. Acta obstetricia et gynecologica Scandinavica, 2022, Volume: 101, Issue:11 Topics: Biomarkers, Tumor; CA-125 Antigen; Carcinoma, Ovarian Epithelial; Cytoreduction Surgical Procedures; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden	2022
Metastatic spread of serous ovarian carcinoma to the bilateral breasts: a rare presentation. BMJ case reports, 2022, Nov-24, Volume: 15, Issue:11 Topics: Carcinoma, Ovarian Epithelial; Cystadenocarcinoma, Serous; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Tomography, X-Ray Computed	2022
Comparison of 68 Ga-FAPI-04 and fluorine-18-fluorodeoxyglucose PET/computed tomography in the detection of ovarian malignancies. Nuclear medicine communications, 2023, 03-01, Volume: 44, Issue:3 Topics: Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines; Retrospective Studies	2023
Hypermetabolic Subserosal Uterine Leiomyoma With Synchronous Atypical Multiple Myeloma Mimicking Ovarian Malignancy With Multiple Bone Metastases on 18F-FDG PET/CT. Clinical nuclear medicine, 2023, Feb-01, Volume: 48, Issue:2 Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Middle Aged; Multiple Myeloma; Myoma; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Uterine Neoplasms	2023
Development and Validation of 18F-FDG PET/CT-Based Models for Predicting Successful Complete Cytoreduction During Primary Cytoreductive Surgery for Advanced Ovarian cancer. Clinical nuclear medicine, 2023, Feb-01, Volume: 48, Issue:2 Topics: Carcinoma, Ovarian Epithelial; Cytoreduction Surgical Procedures; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies	2023
Head-to-head comparison of [ European journal of nuclear medicine and molecular imaging, 2023, Volume: 50, Issue:5 Topics: Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines	2023
Hypermetabolic Broad Ligament Leiomyoma in Postmenopausal Women Mimicking Ovarian Tumors on 18 F-FDG PET/CT. Clinical nuclear medicine, 2023, Apr-01, Volume: 48, Issue:4 Topics: Broad Ligament; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Middle Aged; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Postmenopause; Uterine Neoplasms	2023
The value of PET/CT for cytoreductive surgery selection in recurrent ovarian carcinoma. Journal of gynecologic oncology, 2023, Volume: 34, Issue:3 Topics: Carcinoma, Ovarian Epithelial; Chronic Disease; Cytoreduction Surgical Procedures; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies	2023
Validation of models in predicting residual disease in ovarian cancer: comparing CT urography with PET/CT. Acta radiologica (Stockholm, Sweden : 1987), 2023, Volume: 64, Issue:6 Topics: Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Urography	2023
68Ga-FAPI-04 PET/MR Versus 18F-FDG PET/CT in the Detection of Ovarian Cancer. Clinical nuclear medicine, 2023, Jun-01, Volume: 48, Issue:6 Topics: Abdominal Pain; Aged; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography	2023
Peritoneal and Nodal Gliomatosis Mimicking Metastasis on FDG PET/CT in a Patient With Ovarian Immature Teratoma. Clinical nuclear medicine, 2023, Aug-01, Volume: 48, Issue:8 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Peritoneal Neoplasms; Peritoneum; Positron Emission Tomography Computed Tomography; Teratoma; Young Adult	2023
Ovarian Metastasis From Diffuse Epithelioid Malignant Mesothelioma Revealed by 18 F-FDG PET/CT. Clinical nuclear medicine, 2023, Aug-01, Volume: 48, Issue:8 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Mesothelioma; Mesothelioma, Malignant; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography	2023
Predictive value of PET metabolic parameters for occult lymph node metastases in PET/CT defined node-negative patients with advanced epithelial ovarian cancer. Scientific reports, 2023, 06-09, Volume: 13, Issue:1 Topics: Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies	2023
The value of [18F]FDG PET/CT examination in the detection and differentiation of recurrent ovarian cancer. Nuclear medicine review. Central & Eastern Europe, 2023, Volume: 26, Issue:0 Topics: Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity	2023
Diffuse peritoneal carcinomatosis and Sister Mary Joseph nodule in ovarian carcinoma - exquisite demonstration of the peritoneal reflections on [18F]FDG PET/CT. Nuclear medicine review. Central & Eastern Europe, 2023, Volume: 26, Issue:0 Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sister Mary Joseph's Nodule	2023
Clinical impact of pre-treatment FDG-PET/CT staging of primary ovarian, fallopian tube, and peritoneal cancers in women. Acta obstetricia et gynecologica Scandinavica, 2020, Volume: 99, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Fallopian Tubes; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2020
18F-FDG PET/CT Findings of Ovarian Mesothelioma: A Case Study. Clinical nuclear medicine, 2019, Volume: 44, Issue:11 Topics: Female; Fluorodeoxyglucose F18; Humans; Mesothelioma; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography	2019
Prognostic utility of FDG PET/CT in advanced ovarian, fallopian and primary peritoneal high-grade serous cancer patients before and after neoadjuvant chemotherapy. Annals of nuclear medicine, 2020, Volume: 34, Issue:2 Topics: Aged; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Ovarian Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Time Factors; Treatment Outcome; Tumor Burden	2020
Two cases of ovarian serous surface papillary borderline tumours with discordant 18F-FDG PET features. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2020, Volume: 40, Issue:8 Topics: Adenocarcinoma, Papillary; Adult; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Ovary; Positron-Emission Tomography; Young Adult	2020
The role of 18F-FDG PET/CT-based quantitative metabolic parameters in patients with ovarian clear cell carcinoma. Cancer biomarkers : section A of Disease markers, 2020, Volume: 27, Issue:2 Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glucose; Glycolysis; Humans; Middle Aged; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tumor Burden	2020
Solitary Cerebellar Metastasis of Ovarian Cancer Detected by FDG PET/CT. Clinical nuclear medicine, 2020, Volume: 45, Issue:3 Topics: Cerebellar Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography	2020
Ovarian Metastasis as Initial Presentation of Pancreatic Carcinoma on FDG PET/CT. Clinical nuclear medicine, 2020, Volume: 45, Issue:4 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2020
The maximum standardized uptake value and extent of peritoneal involvement may predict the prognosis of patients with recurrent ovarian cancer after primary treatment: A retrospective clinical study. Medicine, 2020, Volume: 99, Issue:8 Topics: Adult; Aged; Aged, 80 and over; CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Progression-Free Survival; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed	2020
Cerebellar syndrome associated with malignant ovarian tumor and onconeuronal antibodies. Usefulness of the PET/CT with Medicina clinica, 2021, 04-23, Volume: 156, Issue:8 Topics: Cerebellar Diseases; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2021
Hyperestrogenism on 18F-FDG PET/CT in a Patient With Estrogen-Producing Ovarian Clear Cell Carcinoma. Clinical nuclear medicine, 2020, Volume: 45, Issue:7 Topics: Adenocarcinoma, Clear Cell; Aged; Estrogens; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography	2020
Early Assessment of Response to Neoadjuvant Chemotherapy with 18F-FDG-PET/CT in Patients with Advanced-Stage Ovarian Cancer. Cancer research and treatment, 2020, Volume: 52, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cytoreduction Surgical Procedures; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Middle Aged; Neoadjuvant Therapy; Neoplasm, Residual; Ovarian Neoplasms; Ovary; Positron Emission Tomography Computed Tomography; Progression-Free Survival; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Retrospective Studies	2020
Accuracy of peritoneal carcinomatosis extent diagnosis by initial FDG PET CT in epithelial ovarian cancer: A multicentre study of the FRANCOGYN research group. Journal of gynecology obstetrics and human reproduction, 2020, Volume: 49, Issue:9 Topics: Adult; Aged; Aged, 80 and over; CA-125 Antigen; Carcinoma; Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; France; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate	2020
Metastasectomy for Isolated Right-Sided Thoracic Lymph Node Metastasis From Tubal Carcinoma. The American surgeon, 2020, Volume: 86, Issue:5 Topics: Adenocarcinoma; Aged; Chemotherapy, Adjuvant; Contrast Media; Fallopian Tube Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lymph Node Excision; Lymphatic Metastasis; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Robotic Surgical Procedures; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed	2020
The value of 18F-FDG PET/CT imaging combined with detection of CA125 and HE4 in the diagnosis of recurrence and metastasis of ovarian cancer. European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:13 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biopsy; CA-125 Antigen; Chemotherapy, Adjuvant; Cytoreduction Surgical Procedures; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Membrane Proteins; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Time Factors; Treatment Outcome; WAP Four-Disulfide Core Domain Protein 2	2020
FDG PET/CT Findings in a Patient With Ovarian Metastasis of Pheochromocytoma. Clinical nuclear medicine, 2020, Volume: 45, Issue:11 Topics: Adrenal Gland Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Pheochromocytoma; Positron Emission Tomography Computed Tomography	2020
Ovarian dysgerminoma detected by 18F-FDG PET/CT technique: A case report. Medicine, 2020, Nov-06, Volume: 99, Issue:45 Topics: Dysgerminoma; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Young Adult	2020
Glycolytic phenotypes in an evaluation of ovarian carcinoma based on carcinogenesis and BRCA mutation. European journal of radiology, 2020, Volume: 133 Topics: Carcinogenesis; Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Mutation; Neoplasm Recurrence, Local; Ovarian Neoplasms; Phenotype; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden	2020
Metabolic Response by 18F-FDG PET/CT in Metastatic Malignant Struma Ovarii Treated With Targeted Therapies. Clinical nuclear medicine, 2021, Volume: 46, Issue:1 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Molecular Targeted Therapy; Neoplasm Metastasis; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Struma Ovarii; Treatment Outcome	2021
Predicting tumor response and outcome of second-look surgery with European journal of nuclear medicine and molecular imaging, 2021, Volume: 48, Issue:6 Topics: Female; Fluorodeoxyglucose F18; Humans; Indoles; Neoadjuvant Therapy; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Second-Look Surgery; Treatment Outcome; Tumor Burden	2021
18F-FDG PET/CT for Staging and Response Evaluation in a Rare Case of Childhood Ovarian Primitive Neuroectodermal Tumor. Clinical nuclear medicine, 2021, May-01, Volume: 46, Issue:5 Topics: Child; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Neuroectodermal Tumors, Primitive; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Treatment Outcome	2021
Solitary Vulvar Involvement of Ovarian Non-Hodgkin Lymphoma Mimicking Bartholin's Abscess on 18F-FDG PET/CT. Clinical nuclear medicine, 2021, 03-01, Volume: 46, Issue:3 Topics: Abscess; Bartholin's Glands; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Vulva	2021
Ovarian Inflammation Mass Mimicking Recurrent Rectal Cancer 17 Years After Surgery: PET/CT and MRI Findings. Clinical nuclear medicine, 2021, Sep-01, Volume: 46, Issue:9 Topics: Female; Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Rectal Neoplasms	2021
Paraneoplastic cerebellar degeneration: Initial presentation of occult breast cancer. The breast journal, 2021, Volume: 27, Issue:5 Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Paraneoplastic Cerebellar Degeneration	2021
Pretreatment maximum standardized uptake value in 18F-fluorodeoxyglucose positron emission tomography-computed tomography as a prognostic factor for ovarian clear cell carcinoma and low-grade serous carcinoma. Taiwanese journal of obstetrics & gynecology, 2021, Volume: 60, Issue:2 Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Aged, 80 and over; Cystadenocarcinoma, Serous; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Reference Standards; Reference Values; Retrospective Studies; Survival Rate; Young Adult	2021
Assessment of peritoneal metastases with DW-MRI, CT, and FDG PET/CT before cytoreductive surgery for advanced stage epithelial ovarian cancer. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2021, Volume: 47, Issue:8 Topics: Adult; Aged; Carcinoma, Ovarian Epithelial; Cohort Studies; Cytoreduction Surgical Procedures; Diffusion Magnetic Resonance Imaging; Fallopian Tube Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2021
Have Volume-based Parameters of Positron Emission Tomography/Computed Tomography Prognostic Relevance for Patients With Potentially Platinum-responsive Recurrent Ovarian Cancer? A Single Center Italian Study. Anticancer research, 2021, Volume: 41, Issue:4 Topics: Adult; Aged; Carcinoma, Ovarian Epithelial; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Italy; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Platinum Compounds; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; Treatment Outcome; Tumor Burden	2021
Validation of Cancer imaging : the official publication of the International Cancer Imaging Society, 2021, Apr-13, Volume: 21, Issue:1 Topics: Adult; Aged; Carcinoma; Diffusion Magnetic Resonance Imaging; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Pilot Projects; Positron-Emission Tomography; Reproducibility of Results; Survival Analysis; Tomography, X-Ray Computed	2021
COVID arm and PET/FDG imaging. Bulletin du cancer, 2021, Volume: 108, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; BNT162 Vaccine; Deltoid Muscle; Female; Fluorodeoxyglucose F18; Humans; Immunization, Secondary; Incidental Findings; Lymphadenopathy; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2021
Intercostal Brown Adipose Tissue on FDG PET/CT. AJR. American journal of roentgenology, 2021, Volume: 217, Issue:4 Topics: Adipose Tissue, Brown; Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Ribs	2021
Effect of Cerenkov Radiation-Induced Photodynamic Therapy with International journal of molecular sciences, 2021, May-06, Volume: 22, Issue:9 Topics: Animals; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Injections, Intraperitoneal; Mice, Inbred BALB C; Ovarian Neoplasms; Photochemotherapy; Radiation; Xenograft Model Antitumor Assays	2021
Fluorine 18 Fluorodeoxyglucose PET/CT Findings in Gorlin-Goltz Syndrome. Radiology, 2021, Volume: 300, Issue:2 Topics: Adolescent; Basal Cell Nevus Syndrome; Calcinosis; Dura Mater; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Odontogenic Cysts; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2021
Lateral Hepatic Fissure Peritoneal Carcinomatosis as a Pitfall for Hepatic Metastasis of Advanced Ovarian Cancer. Clinical nuclear medicine, 2021, Aug-01, Volume: 46, Issue:8 Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography	2021
Performance of Multiparametric Functional Imaging to Assess Peritoneal Tumor Burden in Ovarian Cancer. Clinical nuclear medicine, 2021, Oct-01, Volume: 46, Issue:10 Topics: Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden	2021
The Search for New 2-18F-FDG PET/CT Imaging Biomarkers in Advanced Ovarian Cancer Patients: Focus on Peritoneal Staging for Guiding Precision Medicine and Management Decisions. Clinical nuclear medicine, 2021, 11-01, Volume: 46, Issue:11 Topics: Biomarkers; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Precision Medicine	2021
Pre treatment and post treatment positron emission tomography-computed tomography (PET-CT) to evaluate treatment response in tuberculous Tubo-Ovarian masses. European journal of obstetrics, gynecology, and reproductive biology, 2021, Volume: 264 Topics: Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals	2021
F-18 FDG PET/CT metabolic tumor volume predicts overall survival in patients with disseminated epithelial ovarian cancer. European journal of radiology, 2017, Volume: 93 Topics: Carcinoma, Ovarian Epithelial; Cytoreduction Surgical Procedures; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Tumor Burden	2017
The role of F18-FDG PET/CT in predicting secondary optimal de-bulking in patients with recurrent ovarian cancer. Surgical oncology, 2017, Volume: 26, Issue:4 Topics: Adult; Aged; Carcinoma, Ovarian Epithelial; Cytoreduction Surgical Procedures; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Patient Selection; Positron Emission Tomography Computed Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies	2017
The application of 18F-FDG PET/CT in ovarian immature teratomas when pathological examination results contradict clinical observations: a case report. Medicine, 2017, Volume: 96, Issue:50 Topics: Adolescent; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Teratoma	2017
Diagnostic value of integrated ¹⁸F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in recurrent epithelial ovarian cancer: accuracy of patient selection for secondary cytoreduction in 134 patients. Journal of gynecologic oncology, 2018, Volume: 29, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Ovarian Epithelial; Cytoreduction Surgical Procedures; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Patient Selection; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Young Adult	2018
Prominent Pulmonary Metastases Without Concurrent Intra-abdominal Metastasis in a Case of Ovarian Carcinoma. Clinical nuclear medicine, 2018, Volume: 43, Issue:5 Topics: Abdominal Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2018
Tumor-to-background ratios of the maximum standardized uptake value could not indicate the prognosis of advanced high-grade serous ovarian cancer patients. Nuclear medicine communications, 2018, Volume: 39, Issue:4 Topics: Adult; Aged; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Grading; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Serous Membrane	2018
Value of [18F]FDG-PET/CT and CA125, serum levels and kinetic parameters, in early detection of ovarian cancer recurrence: Influence of histological subtypes and tumor stages. Medicine, 2018, Volume: 97, Issue:17 Topics: Aged; Biomarkers, Tumor; CA-125 Antigen; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve	2018
Prognostic predictive value of preoperative intratumoral 2-deoxy-2-(18F)fluoro-D-glucose uptake heterogeneity in patients with high-grade serous ovarian cancer. Nuclear medicine communications, 2018, Volume: 39, Issue:10 Topics: Adult; Aged; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Grading; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Period; Prognosis; Retrospective Studies; Tumor Burden	2018
Linked Hexokinase and Glucose-6-Phosphatase Activities Reflect Grade of Ovarian Malignancy. Molecular imaging and biology, 2019, Volume: 21, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glucose-6-Phosphatase; Hexokinase; Humans; Middle Aged; Ovarian Neoplasms	2019
Preoperative omental metastasis-related maximum standardized fluorine-18-fluorodeoxyglucose uptake value can predict chemosensitivity and recurrence in advanced high-grade serous ovarian cancer patients. Nuclear medicine communications, 2018, Volume: 39, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Grading; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Recurrence; Retrospective Studies	2018
Thoracoscopic Resection of Fluorodeoxyglucose-Avid Mediastinal Lymph Nodes Associated with Advanced Ovarian Carcinoma. The Thoracic and cardiovascular surgeon, 2019, Volume: 67, Issue:8 Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Thoracic Surgery, Video-Assisted; Treatment Outcome	2019
Re: The Prognostic Value of 18F-FDG PET/CT in Monitoring Chemotherapy in Ovarian Cancer Both at Initial Diagnosis and at Recurrent Disease. Clinical nuclear medicine, 2019, Volume: 44, Issue:4 Topics: Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis	2019
The ability of whole-body SUVmax in F-18 FDG PET/CT to predict suboptimal cytoreduction during primary debulking surgery for advanced ovarian cancer. Journal of ovarian research, 2019, Feb-04, Volume: 12, Issue:1 Topics: Adult; Aged; Cytoreduction Surgical Procedures; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Models, Biological; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Risk	2019
18F-FDG PET/CT of Lung Adenocarcinoma With Ovarian Metastases. Clinical nuclear medicine, 2019, Volume: 44, Issue:5 Topics: Adenocarcinoma of Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2019
BMC cancer, 2019, Mar-13, Volume: 19, Issue:1 Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis	2019
Behavior of FDG-avid supradiaphragmatic lymph nodes in PET/CT throughout primary therapy in advanced serous epithelial ovarian cancer: a prospective study. Cancer imaging : the official publication of the International Cancer Imaging Society, 2019, May-29, Volume: 19, Issue:1 Topics: Adult; Aged; Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2019
FDG PET/CT in serous psammocarcinoma of the ovary. Clinical nuclear medicine, 2014, Volume: 39, Issue:5 Topics: Adult; Cystadenocarcinoma, Serous; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2014
[18F]FDG and [18F]FLT positron emission tomography imaging following treatment with belinostat in human ovary cancer xenografts in mice. BMC cancer, 2013, Apr-01, Volume: 13 Topics: Animals; Antineoplastic Agents; Dideoxynucleosides; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Hydroxamic Acids; Ki-67 Antigen; Mice; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sulfonamides; Thymidine Kinase; Tumor Burden	2013
The role of the breast radiologist in evaluation of breast incidentalomas detected on 18-fludeoxyglucose positron emission tomography/CT. The British journal of radiology, 2013, Volume: 86, Issue:1026 Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Laryngeal Neoplasms; Lung Neoplasms; Mammography; Middle Aged; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Thyroid Neoplasms; Ultrasonography, Mammary	2013
Isolated splenic metastasis of ovarian cancer detected with 18F-FDG PET/CT. Clinical nuclear medicine, 2014, Volume: 39, Issue:4 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Splenic Neoplasms; Tomography, X-Ray Computed	2014
Detection of a metastatic lesion and tiny yolk sac tumors in two teenage patients by FDG-PET: report of two cases. Surgery today, 2014, Volume: 44, Issue:10 Topics: Adolescent; alpha-Fetoproteins; Biomarkers, Tumor; Bone Neoplasms; Endodermal Sinus Tumor; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals	2014
Prognostic predictive value of total lesion glycolysis from 18F-FDG PET/CT in post-surgical patients with epithelial ovarian cancer. Clinical nuclear medicine, 2013, Volume: 38, Issue:9 Topics: Adult; Aged; Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden	2013
Primary ovarian non-Hodgkin's lymphoma. BMJ case reports, 2013, Jul-29, Volume: 2013 Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals	2013
Rectal lymph node metastasis in recurrent ovarian carcinoma: essential role of 18F-FDG PET/CT in treatment planning. World journal of surgical oncology, 2013, Aug-12, Volume: 11, Issue:1 Topics: Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed	2013
Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study. Gynecologic oncology, 2013, Volume: 131, Issue:2 Topics: Adult; Aged; Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Prospective Studies; Tomography, X-Ray Computed	2013
PET/CT in the staging of patients with a pelvic mass suspicious for ovarian cancer. Gynecologic oncology, 2013, Volume: 131, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography; Young Adult	2013
Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer. Gynecologic oncology, 2013, Volume: 131, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome	2013
Impact of FDG PET in optimizing patient selection for cytoreductive surgery in recurrent ovarian cancer. European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:3 Topics: Adult; Aged; Dissection; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Recurrence; Retrospective Studies	2014
Is there an impact of 18F-FDG PET/CT on the surveillance and clinical management of recurrent ovarian cancer? Research based on a large sample in a single PET/CT center. Nuclear medicine communications, 2014, Volume: 35, Issue:4 Topics: Adult; Aged; Aged, 80 and over; CA-125 Antigen; Decision Making; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed; Treatment Outcome	2014
Preoperative fluorine 18 fluorodeoxyglucose tumoral uptake ratio between upper and lower abdomen in primary advanced-stage ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2013, Volume: 23, Issue:8 Topics: Abdomen; Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Middle Aged; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Republic of Korea; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed	2013
18F-FDG PET/CT and MR findings of ovarian carcinoid within a dermoid cyst. Clinical nuclear medicine, 2014, Volume: 39, Issue:9 Topics: Carcinoid Tumor; Dermoid Cyst; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Mixed Tumor, Malignant; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2014
Negative 18F-2-fluorodeoxyglucose PET/CT predicts good cancer specific survival in patients with a suspicion of recurrent ovarian cancer. European journal of radiology, 2014, Volume: 83, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Germany; Humans; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome	2014
Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: a case series. Gynecologic oncology, 2014, Volume: 132, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cohort Studies; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Infusions, Parenteral; Middle Aged; Minimally Invasive Surgical Procedures; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Positron-Emission Tomography; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Retrospective Studies; Tomography, X-Ray Computed	2014
Imaging of treatment response to the combination of carboplatin and paclitaxel in human ovarian cancer xenograft tumors in mice using FDG and FLT PET. PloS one, 2013, Volume: 8, Issue:12 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Fluorodeoxyglucose F18; Heterografts; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Paclitaxel; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Time Factors	2013
The effectiveness of dual-phase 18F-FDG PET/CT in the detection of epithelial ovarian carcinoma: a pilot study. Journal of ovarian research, 2014, Feb-05, Volume: 7 Topics: Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Ovarian Epithelial; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peritoneal Neoplasms; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed; Tumor Burden; Whole Body Imaging	2014
Utility of 18F-FDG PET/CT in follow-up of patients with low-grade serous carcinoma of the ovary. Gynecologic oncology, 2014, Volume: 133, Issue:1 Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult	2014
Repeatability of quantitative FDG-PET/CT and contrast-enhanced CT in recurrent ovarian carcinoma: test-retest measurements for tumor FDG uptake, diameter, and volume. Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, May-15, Volume: 20, Issue:10 Topics: Adult; Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden	2014
Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses. Investigative radiology, 2014, Volume: 49, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium; Heterocyclic Compounds; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Organometallic Compounds; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed	2014
The role of metabolic tumor volume and total lesion glycolysis on ¹⁸F-FDG PET/CT in the prognosis of epithelial ovarian cancer. European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:10 Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed	2014
Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET. Journal of magnetic resonance imaging : JMRI, 2014, Volume: 40, Issue:5 Topics: Adult; Aged; Carcinoma; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity	2014
Maximum standardized uptake value of fluorodeoxyglucose positron emission tomography/computed tomography is a prognostic factor in ovarian clear cell adenocarcinoma. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2014, Volume: 24, Issue:7 Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Reference Values; Retrospective Studies; Tomography, X-Ray Computed	2014
Simultaneous positron emission tomography/magnetic resonance imaging for whole-body staging in patients with recurrent gynecological malignancies of the pelvis: a comparison to whole-body magnetic resonance imaging alone. Investigative radiology, 2014, Volume: 49, Issue:12 Topics: Adult; Aged; Cervix Uteri; Contrast Media; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Observer Variation; Ovarian Neoplasms; Ovary; Positron-Emission Tomography; Prospective Studies; Reproducibility of Results; Uterine Cervical Neoplasms; Whole Body Imaging; Young Adult	2014
Positron emission tomography combined with computed tomography for diagnosis of synchronous tumors. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2014, Volume: 27, Issue:4 Topics: Aged; Carcinoma, Neuroendocrine; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2014
[(18)F]FDG PET/MRI vs. PET/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial results. European journal of nuclear medicine and molecular imaging, 2015, Volume: 42, Issue:1 Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Staging; Ovarian Neoplasms; Pelvic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Whole Body Imaging	2015
Normal-sized ovary carcinoma syndrome (NOCS) detected with FDG-PET/CT. European journal of gynaecological oncology, 2014, Volume: 35, Issue:5 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2014
Nomogram for predicting incomplete cytoreduction in advanced ovarian cancer patients. Gynecologic oncology, 2015, Volume: 136, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasms, Glandular and Epithelial; Nomograms; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult	2015
The performance of contrast-enhanced FDG PET/CT for the differential diagnosis of unexpected ovarian mass lesions in patients with nongynecologic cancer. Clinical nuclear medicine, 2015, Volume: 40, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Case-Control Studies; Colorectal Neoplasms; Contrast Media; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed	2015
Quantitative metabolic parameters measured on F-18 FDG PET/CT predict survival after relapse in patients with relapsed epithelial ovarian cancer. Gynecologic oncology, 2015, Volume: 136, Issue:3 Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden	2015
Leydig cell tumor incidentally detected by fused FDG-PET/MRI. Endocrine, 2015, Volume: 50, Issue:3 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Leydig Cell Tumor; Magnetic Resonance Imaging; Ovarian Neoplasms; Positron-Emission Tomography	2015
The usefulness of 18F-FDG-PET/CT in discriminating benign from malignant ovarian teratomas. International journal of clinical oncology, 2015, Volume: 20, Issue:5 Topics: Adolescent; Adult; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Teratoma; Tomography, X-Ray Computed; Young Adult	2015
Tubercular Meningitis on 18F-FDG PET/CT: Incidentally Detected and Masquerading as Relapse in a Patient With Ovarian Burkitt Lymphoma. Clinical nuclear medicine, 2015, Volume: 40, Issue:7 Topics: Adolescent; Burkitt Lymphoma; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tuberculosis, Meningeal	2015
Peritoneal carcinomatosis in primary ovarian cancer staging: comparison between MDCT, MRI, and 18F-FDG PET/CT. Clinical nuclear medicine, 2015, Volume: 40, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multidetector Computed Tomography; Ovarian Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
Volume-based quantitative FDG PET/CT metrics and their association with optimal debulking and progression-free survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery. European radiology, 2015, Volume: 25, Issue:11 Topics: Aged; Aged, 80 and over; Carcinoma, Ovarian Epithelial; Cone-Beam Computed Tomography; Cytoreduction Surgical Procedures; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden	2015
F-18 FDG PET/CT findings of metastatic ovarian tumors from gastrointestinal tract origin. Journal of cancer research and clinical oncology, 2015, Volume: 141, Issue:10 Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Gastrointestinal Tract; Humans; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Tomography, X-Ray Computed	2015
Benefits of fluorine-18 fludeoxyglucose positron emission tomography in secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer. The British journal of radiology, 2015, Volume: 88, Issue:1052 Topics: Adult; Aged; Blood Loss, Surgical; Carcinoma, Ovarian Epithelial; Case-Control Studies; Cytoreduction Surgical Procedures; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Postoperative Complications; Radiopharmaceuticals	2015
Utility of PET/CT in the diagnosis of recurrent ovarian cancer depending on CA 125 serum level. Nuklearmedizin. Nuclear medicine, 2015, Volume: 54, Issue:4 Topics: Adult; Aged; Biomarkers, Tumor; CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed	2015
Predictive value of (18)F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study. European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Odds Ratio; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Regression Analysis; Retrospective Studies; Tomography, X-Ray Computed; Young Adult	2016
Unusual Case of Postmenopausal Diffuse Endometriosis Mimicking Metastastic Ovarian Malignancy. Clinical nuclear medicine, 2016, Volume: 41, Issue:2 Topics: Aged; Carcinoma, Ovarian Epithelial; Diagnosis, Differential; Endometriosis; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Metastasis; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Postmenopause; Radiopharmaceuticals; Tomography, X-Ray Computed	2016
18F-FDG-PET/CT can identify histopathological non-responders to platinum-based neoadjuvant chemotherapy in advanced epithelial ovarian cancer. Gynecologic oncology, 2016, Volume: 140, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Models, Statistical; Multimodal Imaging; Neoadjuvant Therapy; Neoplasms, Glandular and Epithelial; Organoplatinum Compounds; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed	2016
Metabolic tumor burden predicts prognosis of ovarian cancer patients who receive platinum-based adjuvant chemotherapy. Cancer science, 2016, Volume: 107, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Carboplatin; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Middle Aged; Ovarian Neoplasms; Paclitaxel; Positron-Emission Tomography; Prognosis; Tumor Burden	2016
Characterization of malignant ovarian mass on [18F]FDG PET/CT: using metabolic indices and degree of solidity. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2019, Volume: 63, Issue:1 Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tumor Burden	2019
Ovarian Hyperstimulation and Oocyte Harvesting Prior to Systemic Chemotherapy-A Possible Pitfall in 18F-FDG PET/CT Staging of Oncologic Patients. Clinical nuclear medicine, 2016, Volume: 41, Issue:8 Topics: Adult; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Oocyte Retrieval; Ovarian Neoplasms; Ovulation Induction; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2016
Clinical usefulness of post-treatment FDG PET/CT in patients with ovarian malignancy. Annals of nuclear medicine, 2016, Volume: 30, Issue:9 Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Young Adult	2016
Virchow's node metastasis: an unusual presentation of ovarian cancer. European journal of gynaecological oncology, 2016, Volume: 37, Issue:3 Topics: Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms	2016
Bi-insular cortical involvement in anti-NMDA-receptor encephalitis - a case report. BMC neurology, 2016, Aug-08, Volume: 16 Topics: Adult; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Antibodies; Cerebral Cortex; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hippocampus; Humans; Immunotherapy; N-Methylaspartate; Ovarian Neoplasms; Positron-Emission Tomography; Prefrontal Cortex; Teratoma; Whole Body Imaging	2016
Extensive Metastases on 18F-FDG PET/CT in Primary Lymphoepithelioma-Like Carcinoma of the Ovary. Clinical nuclear medicine, 2016, Volume: 41, Issue:11 Topics: Bone Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Middle Aged; Omentum; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2016
Tumor Heterogeneity Detected by 68Ga DOTATOC and 18F-FDG PET/CTs in One Malignant Insulinoma With Involvement of the Portal Splenic Confluence and Ovarian Metastases. Clinical nuclear medicine, 2016, Volume: 41, Issue:11 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Insulinoma; Octreotide; Organometallic Compounds; Ovarian Neoplasms; Pancreatic Neoplasms; Portal Vein; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Spleen	2016
Use of (18)F-FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue. European journal of radiology, 2016, Volume: 85, Issue:10 Topics: Adult; Aged; Carcinoma; Carcinoma, Ovarian Epithelial; Cytoreduction Surgical Procedures; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden	2016
18F-Fluorodeoxyglucose Uptake in Anti-N-Methyl-D-Aspartate-Receptor Encephalitis Associated With an Immature Teratoma. Clinical nuclear medicine, 2017, Volume: 42, Issue:2 Topics: Adult; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Teratoma	2017
FDG-PET-positive ovarian thecoma with GLUT5 expression: Five cases. The journal of obstetrics and gynaecology research, 2017, Volume: 43, Issue:3 Topics: Aged; False Positive Reactions; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 5; Humans; Magnetic Resonance Imaging; Middle Aged; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Postmenopause; Thecoma	2017
Unsuspected Metastatic Ovarian Cancer Revealed by 18F-NaF PET/CT Performed to Evaluate Lower-Back Pain. Clinical nuclear medicine, 2017, Volume: 42, Issue:2 Topics: Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Low Back Pain; Middle Aged; Neoplasm Metastasis; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sodium Fluoride	2017
Intense fluorodeoxyglucose uptake by a benign sclerosing stromal tumor of the ovary. Taiwanese journal of obstetrics & gynecology, 2016, Volume: 55, Issue:6 Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Pregnancy; Radiopharmaceuticals; Sex Cord-Gonadal Stromal Tumors; Young Adult	2016
Low uptake of fluorodeoxyglucose in positron emission tomography/computed tomography in ovarian clear cell carcinoma may reflect glutaminolysis of its cancer stem cell-like properties. Oncology reports, 2017, Volume: 37, Issue:3 Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Blotting, Western; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Glutamine; Humans; Middle Aged; Neoplasm Staging; Neoplastic Stem Cells; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Signal Transduction; Tumor Cells, Cultured; Young Adult	2017
Novel perioperative imaging with 18F-FDG PET/CT and intraoperative 18F-FDG detection using a handheld gamma probe in recurrent ovarian cancer. Gynecologic oncology, 2008, Volume: 110, Issue:2 Topics: Adult; Cystadenocarcinoma, Serous; Female; Fluorodeoxyglucose F18; Humans; Intraoperative Care; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2008
Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT. European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:10 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging	2008
A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PET/CT and staging laparoscopy. Oncology, 2008, Volume: 75, Issue:3-4 Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2008
FDG uptake in parahepatic brown fat mimics peritoneal carcinomatosis in a malignant ovarian germ cell tumor: resolution with temperature control. Clinical nuclear medicine, 2008, Volume: 33, Issue:11 Topics: Adipose Tissue, Brown; Carcinoma, Embryonal; Child; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Heating; Humans; Ovarian Neoplasms; Ovariectomy; Peritoneal Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2008
18F-FDG PET/CT evaluation of patients with ovarian carcinoma. Nuclear medicine communications, 2008, Volume: 29, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed	2008
[(18)F-FDG PET-CT in detecting the primary tumor in patients with metastatic cancers of unknown primary origin]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2008, Volume: 30, Issue:9 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Ovarian Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2008
Physiologic FDG uptake in the ovary together with an abdominal wall leiomyoma mimicking metastasizing ovarian cancer on PET/CT imaging. Clinical nuclear medicine, 2009, Volume: 34, Issue:4 Topics: Adult; Diagnosis, Differential; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Neoplasm Metastasis; Ovarian Neoplasms; Ovary; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2009
Dual-phase F-18 FDG PET/CT scanning in the suspicion of relapse of ovarian neoplasia. Clinical nuclear medicine, 2009, Volume: 34, Issue:2 Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed	2009
Monitoring therapeutic response of human ovarian cancer to 17-DMAG by noninvasive PET imaging with (64)Cu-DOTA-trastuzumab. European journal of nuclear medicine and molecular imaging, 2009, Volume: 36, Issue:9 Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzoquinones; Cell Line, Tumor; Copper Radioisotopes; Female; Fluorodeoxyglucose F18; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Mice; Mice, Nude; Neoplasm Transplantation; Organometallic Compounds; Ovarian Neoplasms; Positron-Emission Tomography; Receptor, ErbB-2; Tissue Distribution; Trastuzumab	2009
Peritoneal carcinomatosis from ovarian cancer: the role of CT and [¹⁸F]FDG-PET/CT. Abdominal imaging, 2010, Volume: 35, Issue:6 Topics: Aged; Carcinoma; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Triiodobenzoic Acids	2010
F-18 FDG PET-CT findings in a case of normal-sized ovarian cancer syndrome. Clinical nuclear medicine, 2009, Volume: 34, Issue:10 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron-Emission Tomography; Syndrome; Tomography, X-Ray Computed	2009
Variable F-18 fluorodeoxyglucose avidity of metastatic recurrent adult granulosa cell tumor. Clinical nuclear medicine, 2009, Volume: 34, Issue:10 Topics: Abdominal Neoplasms; Adult; Female; Fluorodeoxyglucose F18; Granulosa Cell Tumor; Humans; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed	2009
Positron emission tomography and granulosa cell tumor recurrence: a report of 2 cases. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2009, Volume: 19, Issue:9 Topics: Aged; Female; Fluorodeoxyglucose F18; Granulosa Cell Tumor; Humans; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Recurrence	2009
Diagnostic performance of fluorodeoxyglucose positron emission tomography/magnetic resonance imaging fusion images of gynecological malignant tumors: comparison with positron emission tomography/computed tomography. Japanese journal of radiology, 2010, Volume: 28, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Hysterosalpingography; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Observer Variation; Ovarian Neoplasms; Ovary; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Uterus	2010
Combined positron emission tomography-computed tomography and tumor markers for detecting recurrent ovarian cancer. Archives of gynecology and obstetrics, 2011, Volume: 283, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2011
Clinical value of FDG PET/CT in the diagnosis of suspected recurrent ovarian cancer: is there an impact of FDG PET/CT on patient management? European journal of nuclear medicine and molecular imaging, 2010, Volume: 37, Issue:7 Topics: Adult; Aged; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Whole Body Imaging	2010
Use of F 18-fluoro-D-glucose-positron emission tomography-computed tomography to localize a hilar cell tumor of the ovary. Fertility and sterility, 2010, Volume: 94, Issue:2 Topics: Androgens; Female; Fluorodeoxyglucose F18; Hirsutism; Humans; Middle Aged; Neoplasms, Gonadal Tissue; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2010
Imaging-guided percutaneous radiofrequency ablation of retroperitoneal metastatic disease in patients with gynecologic malignancies: clinical experience with eight patients. AJR. American journal of roentgenology, 2010, Volume: 194, Issue:6 Topics: Aged; Catheter Ablation; Chemotherapy, Adjuvant; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Radiography, Interventional; Radiopharmaceuticals; Retroperitoneal Neoplasms; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome	2010
Impact of positron emission tomography/computed tomography in the management of patients with epithelial ovarian carcinoma after treatment. Archives of gynecology and obstetrics, 2011, Volume: 283, Issue:5 Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed	2011
Clinical utility of positron emission tomography/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2010, Volume: 20, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; CA-125 Antigen; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reference Values; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed	2010
FDG-PET/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy. European journal of radiology, 2011, Volume: 80, Issue:2 Topics: Aged; Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Middle Aged; Multimodal Imaging; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2011
Standardized FDG uptake as a prognostic variable and as a predictor of incomplete cytoreduction in primary advanced ovarian cancer. Acta oncologica (Stockholm, Sweden), 2011, Volume: 50, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Algorithms; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Ovarian Neoplasms; Ovariectomy; Positron-Emission Tomography; Prognosis; Survival Analysis	2011
Pgp inhibition by UIC2 antibody can be followed in vitro by using tumor-diagnostic radiotracers, 99mTc-MIBI and 18FDG. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2010, Dec-23, Volume: 41, Issue:5 Topics: Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cyclosporine; Daunorubicin; Drug Resistance, Multiple; Female; Fluorodeoxyglucose F18; Glucose; Humans; Ovarian Neoplasms; Paclitaxel; Protein Binding; Rhodamine 123; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured	2010
Early detection of response to experimental chemotherapeutic Top216 with [18F]FLT and [18F]FDG PET in human ovary cancer xenografts in mice. PloS one, 2010, Sep-24, Volume: 5, Issue:9 Topics: Animals; Antineoplastic Agents; Cell Proliferation; Dideoxynucleosides; Disease Models, Animal; Drug Monitoring; Female; Fluorodeoxyglucose F18; Humans; Mice; Mice, Nude; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Xenograft Model Antitumor Assays	2010
Jejunal cancer detected after a resection of bilateral ovarian metastasis: report of a case. Surgery today, 2010, Volume: 40, Issue:11 Topics: Adenocarcinoma; Chemotherapy, Adjuvant; Double-Balloon Enteroscopy; Female; Fluorodeoxyglucose F18; Humans; Jejunal Neoplasms; Laparotomy; Magnetic Resonance Imaging; Middle Aged; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed	2010
[18F]FDG-PET/CT monitoring early identifies advanced ovarian cancer patients who will benefit from prolonged neo-adjuvant chemotherapy. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2011, Volume: 55, Issue:1 Topics: Adult; Aged; Carboplatin; Chemotherapy, Adjuvant; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed	2011
Value of FDG PET/CT in patients with treated ovarian cancer and raised CA125 serum levels. Molecular imaging and biology, 2012, Volume: 14, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed; Young Adult	2012
FDG PET/CT features of ovarian metastasis. Clinical radiology, 2011, Volume: 66, Issue:3 Topics: Adult; Breast Neoplasms; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms	2011
Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence. European journal of gastroenterology & hepatology, 2011, Volume: 23, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed	2011
Evaluation of an intraperitoneal ovarian cancer syngeneic mouse model using 18F-FDG MicroPET imaging. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2011, Volume: 21, Issue:1 Topics: Animals; Carcinoma; Female; Fluorodeoxyglucose F18; Injections, Intraperitoneal; Mice; Mice, Inbred C57BL; Models, Animal; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals	2011
Gynecological cancers. Methods in molecular biology (Clifton, N.J.), 2011, Volume: 727 Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Neoplasms	2011
FDG-PET/CT for diagnosis of primary ovarian cancer. Nuclear medicine communications, 2011, Volume: 32, Issue:7 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Positron-Emission Tomography; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed	2011
Growing teratoma syndrome of the ovary: a case report with FDG-PET findings. The journal of obstetrics and gynaecology research, 2011, Volume: 37, Issue:7 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Reoperation; Teratoma; Treatment Outcome; Tumor Burden	2011
Early detection of recurrent ovarian cancer in patients with low-level increases in serum CA-125 levels by 2-[F-18]fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography. Cancer biotherapy & radiopharmaceuticals, 2011, Volume: 26, Issue:2 Topics: Adult; Biomarkers, Tumor; CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2011
Whole-body FDG PET/CT in diagnosis of internal mammary nodal metastasis of ovarian carcinosarcoma. Clinical nuclear medicine, 2011, Volume: 36, Issue:6 Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Ovarian Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging	2011
Diffuse intraabdominal fibrosis and inflammation mimicking peritoneal carcinomatosis recurred after surgery for borderline ovarian tumor misdiagnosed by 18F-fluorodeoxyglucose-positron emission tomography. European journal of gynaecological oncology, 2011, Volume: 32, Issue:2 Topics: Adenocarcinoma, Mucinous; Adult; Carcinoma; Diagnosis, Differential; Diagnostic Errors; Female; Fibrosis; Fluorodeoxyglucose F18; Humans; Inflammation; Ovarian Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Recurrence	2011
Leydig cell tumour of the ovary localised with positron emission tomography/computed tomography. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2011, Volume: 27, Issue:10 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Leydig Cell Tumor; Multimodal Imaging; Ovarian Neoplasms; Ovariectomy; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Virilism	2011
Recurrent ovarian carcinoma presenting as a solitary sternal metastasis on FDG PET/CT. Clinical nuclear medicine, 2011, Volume: 36, Issue:8 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron-Emission Tomography; Recurrence; Sternum; Thoracic Neoplasms; Tomography, X-Ray Computed	2011
Calcified metastases from ovarian carcinoma highlighted by F-18 FDG PET/CT: report of two cases. Abdominal imaging, 2012, Volume: 37, Issue:4 Topics: Adult; Aged; Calcinosis; Carcinoma, Papillary; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Metastasis; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2012
18F-FDG PET-CT and USG/CT in benign and malignant ovarian tumors with postoperative histopathological correlation. Ginekologia polska, 2011, Volume: 82, Issue:8 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Ovarian Diseases; Ovarian Neoplasms; Poland; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color	2011
Ovarian thecoma mimicking carcinoma on F-18 FDG PET in a postmenopausal woman with elevated CA-125. Clinical nuclear medicine, 2011, Volume: 36, Issue:12 Topics: Aged; CA-125 Antigen; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron-Emission Tomography; Postmenopause; Thecoma; Tomography, X-Ray Computed	2011
Prognostic significance of mediastinal 18F-FDG uptake in PET/CT in advanced ovarian cancer. European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:3 Topics: Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Mediastinum; Middle Aged; Multimodal Imaging; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed	2012
Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis in patients with epithelial ovarian cancer. Annals of surgical oncology, 2012, Volume: 19, Issue:6 Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed	2012
FDG PET/CT in ovarian cancer: what about treatment response and prognosis? Clinical nuclear medicine, 2012, Volume: 37, Issue:1 Topics: Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2012
Relationship among glycolytic phenotype, grade, and histological subtype in ovarian carcinoma. Clinical nuclear medicine, 2012, Volume: 37, Issue:1 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed	2012
Diagnostic value of PET/CT is similar to that of conventional MRI and even better for detecting small peritoneal implants in patients with recurrent ovarian cancer. Nuclear medicine communications, 2012, Volume: 33, Issue:5 Topics: Abdominal Neoplasms; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Ovarian Neoplasms; Pelvic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed	2012
The pretreatment of maximum standardized uptake values (SUVmax) of the primary tumor is predictor for poor prognosis for patients with epithelial ovarian cancer. Acta medica Okayama, 2012, Volume: 66, Issue:1 Topics: Adult; Aged; C-Reactive Protein; CA-125 Antigen; Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed	2012
Bilateral ovarian metastases from gastric carcinoma on FDG PET/CT. Clinical nuclear medicine, 2012, Volume: 37, Issue:5 Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed	2012
Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose- and 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography as biomarkers of therapy response in platinum-resistant ovarian cancer. Molecular imaging and biology, 2012, Volume: 14, Issue:6 Topics: Animals; Biomarkers, Tumor; Blotting, Western; Cell Line, Tumor; Chlorpropamide; Dideoxynucleosides; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Mice; Ovarian Neoplasms; Platinum; Positron-Emission Tomography; Time Factors; Treatment Outcome; Xenograft Model Antitumor Assays	2012
Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary. Cancer epidemiology, 2012, Volume: 36, Issue:5 Topics: Adult; Aged; Breast Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Unknown Primary; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prostatic Neoplasms; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Urologic Neoplasms	2012
[18F-FDG PET/CT in patients, treated for ovarian cancer, with elevated CA 125 levels but no evidence of recurrence on conventional imaging]. Akusherstvo i ginekologiia, 2012, Volume: 51, Issue:1 Topics: Adult; CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Ovarian Neoplasms; Ovary; Positron-Emission Tomography; Tomography, X-Ray Computed	2012
Assessment of ovarian teratoma and lymphadenopathy by 18F-FDG PET/CT. Clinical nuclear medicine, 2012, Volume: 37, Issue:8 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Diseases; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Teratoma; Tomography, X-Ray Computed	2012
Revisiting the clinical value of 18F-FDG PET/CT in detection of recurrent epithelial ovarian carcinomas: correlation with histology, serum CA-125 assay, and conventional radiological modalities. Clinical nuclear medicine, 2012, Volume: 37, Issue:8 Topics: CA-125 Antigen; Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed	2012
Positron emission tomography/computed tomography predictors of overall survival in stage IIIC/IV ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2012, Volume: 22, Issue:7 Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed	2012
Detecting peritoneal dissemination of ovarian cancer in mice by DWIBS. Magnetic resonance imaging, 2013, Volume: 31, Issue:2 Topics: Animals; Carcinoma; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Motion; Ovarian Neoplasms; Peritoneal Neoplasms; Peritoneum; Positron-Emission Tomography; Respiration; X-Ray Microtomography	2013
Isolated adrenal metastasis of small cell neuroendocrine carcinoma of the ovary detected with FDG-PET/CT. Revista espanola de medicina nuclear e imagen molecular, 2012, Volume: 31, Issue:5 Topics: Adrenal Gland Neoplasms; Aged; Carcinoma, Neuroendocrine; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Multimodal Imaging; Ovarian Neoplasms; Ovariectomy; Positron-Emission Tomography; Radiopharmaceuticals; Salpingectomy; Tomography, X-Ray Computed	2012
Unilateral ovarian metastasis from gastric mucinous adenocarcinoma visualized on FDG PET/CT. European review for medical and pharmacological sciences, 2012, Volume: 16 Suppl 4 Topics: Adenocarcinoma, Mucinous; Adult; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed	2012
[Peritoneal carcinomatosis from ovarian cancer: role of 18F-FDG-PET/CT and CA125]. Recenti progressi in medicina, 2012, Volume: 103, Issue:11 Topics: Adult; Aged; Aged, 80 and over; CA-125 Antigen; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed	2012
[18F]FLT and [18F]FDG PET for non-invasive treatment monitoring of the nicotinamide phosphoribosyltransferase inhibitor APO866 in human xenografts. PloS one, 2013, Volume: 8, Issue:1 Topics: Acrylamides; Animals; Antineoplastic Agents; Biological Transport; Cell Proliferation; Clinical Trials, Phase II as Topic; Dideoxynucleosides; Drug Monitoring; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gene Expression; Humans; Ki-67 Antigen; Mice; Mice, Nude; Nicotinamide Phosphoribosyltransferase; Ovarian Neoplasms; Piperidines; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Tumor Burden; Xenograft Model Antitumor Assays	2013
High impact of FDG-PET/CT in diagnostic strategies for ovarian cancer. Acta radiologica (Stockholm, Sweden : 1987), 2013, Apr-01, Volume: 54, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Statistics, Nonparametric; Tomography, X-Ray Computed	2013
Peritoneal carcinomatosis in patients with ovarian cancer: enhanced CT versus 18F-FDG PET/CT. Clinical nuclear medicine, 2013, Volume: 38, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Radiography, Abdominal; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed	2013
Plasmacytoma of the ovary: additional role of 18F-FDG PET/CT. Clinical nuclear medicine, 2013, Volume: 38, Issue:5 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Ovarian Neoplasms; Plasmacytoma; Positron-Emission Tomography; Tomography, X-Ray Computed	2013
[Role of positron emission tomography in detecting recurrent epithelial ovarian carcinoma]. Zhonghua fu chan ke za zhi, 2002, Jun-18, Volume: 37, Issue:6 Topics: CA-125 Antigen; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed	2002
Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancer. AJR. American journal of roentgenology, 2002, Volume: 179, Issue:2 Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed	2002
FDG positron emission tomography for the detection of ovarian cancer. TEC bulletin, 2002, Jul-08, Volume: 19, Issue:2 Topics: Blue Cross Blue Shield Insurance Plans; Drug Approval; Female; Flow Cytometry; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Insurance Coverage; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Ovarian Neoplasms; Radiopharmaceuticals; Technology Assessment, Biomedical; Tomography, Emission-Computed; United States	2002
Usefulness of whole body positron emission tomography (PET) with 18F-fluoro-2-deoxyglucose (FDG) to detect recurrent ovarian cancer based on asymptomatically elevated serum levels of tumor marker. Neoplasma, 2002, Volume: 49, Issue:5 Topics: Aged; Biomarkers, Tumor; CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed	2002
Whole-body PET with FDG is useful for following up an ovarian cancer patient with only rising CA-125 levels within the normal range. Annals of nuclear medicine, 2002, Volume: 16, Issue:7 Topics: CA-125 Antigen; Cystadenocarcinoma, Serous; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Whole-Body Counting	2002
Evaluation of 18F-FDG PET with bladder irrigation in patients with uterine and ovarian tumors. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Artifacts; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Radiopharmaceuticals; Therapeutic Irrigation; Tomography, Emission-Computed; Urinary Bladder; Uterine Cervical Neoplasms; Uterine Neoplasms	2003
Positron emission tomography with FDG in the detection of peritoneal and retroperitoneal metastases of ovarian cancer. Gynecologic and obstetric investigation, 2003, Volume: 55, Issue:3 Topics: Adult; Aged; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Prospective Studies; Retroperitoneal Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed	2003
Peritoneal carcinomatosis: role of (18)F-FDG PET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:9 Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Carcinoma; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Mesothelial; Ovarian Neoplasms; Peritoneal Neoplasms; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms	2003
Incremental benefits of FDG positron emission tomography over CT alone for the preoperative staging of ovarian cancer. AJR. American journal of roentgenology, 2004, Volume: 182, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed; Tomography, X-Ray Computed	2004
Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary. International journal of cancer, 2004, May-10, Volume: 109, Issue:6 Topics: Adenocarcinoma, Mucinous; Biomarkers, Tumor; Carcinoma, Endometrioid; Cell Division; Cystadenocarcinoma, Serous; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Humans; Ki-67 Antigen; Monosaccharide Transport Proteins; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed	2004
Bilateral ovarian metastases from colon carcinoma visualized on F-18 FDG PET scan. Clinical nuclear medicine, 2004, Volume: 29, Issue:5 Topics: Antibodies, Monoclonal; Female; Fluorodeoxyglucose F18; Humans; Krukenberg Tumor; Organotechnetium Compounds; Ovarian Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed	2004
Relapse after more than 20 years of follow-up for epithelial ovarian carcinoma. Obstetrics and gynecology, 2004, Volume: 103, Issue:5 Pt 2 Topics: Abdominal Pain; Adult; Appendicitis; Axilla; Cystadenocarcinoma, Serous; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Radiopharmaceuticals; Time Factors	2004
[2003 update of recommendations for clinical practice: standards, options and recommendations for the use of FDG-PET in the management of gynaecological and breast cancers]. Gynecologie, obstetrique & fertilite, 2004, Volume: 32, Issue:4 Topics: Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Neoplasm Metastasis; Neoplasm, Residual; Ovarian Neoplasms; Tomography, Emission-Computed; Uterine Neoplasms; Vaginal Neoplasms	2004
Use of FDG-PET in the differential diagnosis of a single bone lesion in ovarian cancer. Clinical nuclear medicine, 2004, Volume: 29, Issue:3 Topics: Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Ovarian Neoplasms; Pelvic Bones; Pelvic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate	2004
Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis. Neurology, 2004, Jul-27, Volume: 63, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antibody Specificity; Autoantibodies; Autoimmune Diseases of the Nervous System; Carcinoma; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Neuroblastoma; Neurons; Ovarian Neoplasms; Paraneoplastic Polyneuropathy; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed	2004
The influence of CA 125 and CEA levels on the results of (18)F-deoxyglucose positron emission tomography in suspected recurrence of epithelial ovarian cancer. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2004, Volume: 180, Issue:8 Topics: Biomarkers, Tumor; CA-125 Antigen; Carcinoembryonic Antigen; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Recurrence; Reference Values; Retrospective Studies	2004
Laparoscopic resection of occult metastasis using the combination of FDG-positron emission tomography/computed tomography image fusion with intraoperative probe guidance in a woman with recurrent ovarian cancer. Gynecologic oncology, 2005, Volume: 96, Issue:1 Topics: Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2005
Combined positron emission tomography and computed tomography for the detection of recurrent ovarian mucinous adenocarcinoma. Gynecologic oncology, 2005, Volume: 96, Issue:3 Topics: Adenocarcinoma, Mucinous; Aged; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2005
Incidental ovarian 18F-FDG accumulation on PET: correlation with the menstrual cycle. European journal of nuclear medicine and molecular imaging, 2005, Volume: 32, Issue:7 Topics: Adult; Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Spectroscopy; Menopause; Menstrual Cycle; Middle Aged; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Ovary; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Uterine Cervical Neoplasms	2005
FDG-PET for management of cervical and ovarian cancer. Gynecologic oncology, 2005, Volume: 97, Issue:1 Topics: CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Uterine Cervical Neoplasms	2005
[Is 18F-FDG-PET suitable for therapy monitoring after palliative photodynamic therapy of non-resectable hilar cholangiocarcinoma?]. Zeitschrift fur Gastroenterologie, 2005, Volume: 43, Issue:5 Topics: Bile Duct Neoplasms; Cholestasis, Intrahepatic; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hematoporphyrin Photoradiation; Hepatic Duct, Common; Humans; Klatskin Tumor; Male; Neoplasm Staging; Outcome Assessment, Health Care; Ovarian Neoplasms; Palliative Care; Peritoneal Neoplasms; Positron-Emission Tomography; Prospective Studies	2005
Combined FDG-positron emission tomography and computed tomography for the detection of ovarian cancer recurrence in an inguinal hernia sac. Gynecologic oncology, 2005, Volume: 98, Issue:3 Topics: Female; Fluorodeoxyglucose F18; Hernia, Inguinal; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2005
False-positive fluorine-18 fluorodeoxy-D-glucose positron emission tomography imaging caused by retained gauze in a woman with recurrent ovarian cancer: a case report. European journal of gynaecological oncology, 2005, Volume: 26, Issue:4 Topics: Adenocarcinoma, Papillary; False Positive Reactions; Female; Fluorodeoxyglucose F18; Foreign-Body Reaction; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Surgical Procedures, Operative; Surgical Sponges	2005
Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Oct-20, Volume: 23, Issue:30 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Risk Factors; Survival Rate	2005
Ovulation and increased FDG uptake on PET: potential for a false-positive result. Clinical nuclear medicine, 2005, Volume: 30, Issue:10 Topics: Carcinoma, Squamous Cell; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Ovulation; Positron-Emission Tomography; Radiopharmaceuticals; Urethral Neoplasms	2005
Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Annals of neurology, 2005, Volume: 58, Issue:4 Topics: Adolescent; Adult; Animals; Antibodies, Neoplasm; Blotting, Western; Brain; Cells, Cultured; Encephalitis; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Hippocampus; Humans; Hypoventilation; Immunoglobulin G; Immunohistochemistry; Magnetic Resonance Imaging; Mental Disorders; Neurons; Ovarian Neoplasms; Positron-Emission Tomography; Rats; Teratoma; Time Factors	2005
Use of positron emission tomography scans in ovarian cancer: a diagnostic technique in search of an indication. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Oct-20, Volume: 23, Issue:30 Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals	2005
Ovarian cancer, diagnosed with PET, with bilateral inguinal lymphadenopathy as primary presenting sign. Gynecologic oncology, 2006, Volume: 100, Issue:3 Topics: Female; Fluorodeoxyglucose F18; Humans; Inguinal Canal; Lymphatic Diseases; Middle Aged; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals	2006
Image in endocrinology: testosterone-secreting ovarian tumor localized with (fluorine-18)-2-deoxyglucose positron emission tomography. The Journal of clinical endocrinology and metabolism, 2006, Volume: 91, Issue:3 Topics: Adult; Amenorrhea; Female; Fluorodeoxyglucose F18; Hirsutism; Humans; Ovarian Neoplasms; Ovariectomy; Positron-Emission Tomography; Radioisotopes; Testosterone	2006
Supra-clavicular lymph node metastatic spread in patients with ovarian cancer disclosed at 18F-FDG-PET/CT: an unusual finding. Cancer imaging : the official publication of the International Cancer Imaging Society, 2006, Mar-23, Volume: 6 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Ovarian Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2006
A case of non-hodgkin's lymphoma of the ovary: usefulness of 18F-FDG PET for staging and assessment of the therapeutic response. Annals of nuclear medicine, 2006, Volume: 20, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Treatment Outcome; Vincristine	2006
[Update of 'standards, options and recommendations' for FDG-PET in breast and gynaecological cancers]. Gynecologie, obstetrique & fertilite, 2006, Volume: 34, Issue:5 Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; France; Genital Neoplasms, Female; Humans; Neoplasm Metastasis; Ovarian Neoplasms; Practice Guidelines as Topic; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Neoplasms; Vaginal Neoplasms	2006
[Synthesis bulletin of 2005 surveillance. Clinical practice recommendations: the use of PET-FDG in cancers of the breast, ovary and uterus]. Bulletin du cancer, 2006, Volume: 93, Issue:4 Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Neoplasms	2006
Intense FDG uptake of metastatic clear cell carcinoma from the ovary in a uterine leiomyoma. Clinical nuclear medicine, 2006, Volume: 31, Issue:7 Topics: Adenocarcinoma, Clear Cell; Antigens, Neoplasm; Biomarkers, Tumor; CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Middle Aged; Neoplasms, Multiple Primary; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Neoplasms	2006
18F-fluorodeoxyglucose positron emission tomography in patients with recurrent ovarian cancer: in comparison with vascularity, Ki-67, p53, and histologic grade. European radiology, 2007, Volume: 17, Issue:2 Topics: Adult; Aged; Analysis of Variance; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Immunohistochemistry; Ki-67 Antigen; Logistic Models; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Research Design; Retrospective Studies; Tumor Suppressor Protein p53	2007
[2005 monitoring report: use of positron emission tomography with fluorodeoxyglucose in the management of patients with breast cancer, ovarian cancer, and uterine cancer]. Gynecologie, obstetrique & fertilite, 2006, Volume: 34, Issue:5 Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; France; Humans; Meta-Analysis as Topic; Neoplasm Metastasis; Ovarian Neoplasms; Practice Guidelines as Topic; Quality of Health Care; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Neoplasms	2006
Positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer. International journal of clinical oncology, 2006, Volume: 11, Issue:3 Topics: Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals	2006
18F-FDG PET/CT in a patient with lymph node metastasis from ovarian adenocarcinoma. AJR. American journal of roentgenology, 2006, Volume: 187, Issue:3 Topics: Adenocarcinoma; Aged; Calcinosis; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Ovarian Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed	2006
Ovarian vascular pedicle sign in ovarian metastasis arising from gall bladder carcinoma. Australasian radiology, 2006, Volume: 50, Issue:5 Topics: Adenocarcinoma; Contrast Media; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Middle Aged; Ovarian Neoplasms; Ovary; Positron-Emission Tomography; Radiographic Image Enhancement; Rare Diseases; Tomography, X-Ray Computed; Ultrasonography	2006
FDG PET and PET/CT for the detection of the primary tumour in patients with cervical non-squamous cell carcinoma metastasis of an unknown primary. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2007, Volume: 264, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed	2007
Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer. European journal of nuclear medicine and molecular imaging, 2007, Volume: 34, Issue:5 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome	2007
Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer. Gynecologic oncology, 2007, Volume: 105, Issue:1 Topics: Adult; Aged; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed	2007
[The value of FDG PET/CT, ultrasound and CT in diagnosing recurrent ovarian carcinoma]. Ginekologia polska, 2006, Volume: 77, Issue:10 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Poland; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Women's Health	2006
[Malignant struma ovarii: false positive PET image for suspected metastasis due to sarcoidosis]. Annales d'endocrinologie, 2007, Volume: 68, Issue:1 Topics: Adult; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Thyroid Gland	2007
Diagnostic accuracy of FDG PET in the follow-up of platinum-sensitive epithelial ovarian carcinoma. European journal of nuclear medicine and molecular imaging, 2007, Volume: 34, Issue:9 Topics: Adult; Antineoplastic Agents; CA-125 Antigen; Cisplatin; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Recurrence; Reproducibility of Results; Whole Body Imaging	2007
[Leydig cell tumor as a cause of hirsutism in a postmenopausal woman]. Medizinische Klinik (Munich, Germany : 1983), 2007, Mar-15, Volume: 102, Issue:3 Topics: Female; Fluorodeoxyglucose F18; Gonadal Steroid Hormones; Hirsutism; Humans; Leydig Cell Tumor; Middle Aged; Ovarian Neoplasms; Ovary; Positron-Emission Tomography; Testosterone	2007
A rare gynecological case of paraneoplastic cerebellar degeneration discovered by FDG-PET. Gynecologic oncology, 2007, Volume: 105, Issue:2 Topics: Adenocarcinoma; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Paraneoplastic Cerebellar Degeneration; Positron-Emission Tomography; Radiopharmaceuticals	2007
Chemotherapy in metastatic malignant triton tumor: report on two cases. Oncology reports, 2007, Volume: 18, Issue:4 Topics: Adult; Antineoplastic Agents; Cecal Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Ileal Neoplasms; Liver Neoplasms; Male; Neoadjuvant Therapy; Neurilemmoma; Neurofibromatosis 1; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Neoplasms	2007
Correspondence: diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions. Nuclear medicine communications, 2007, Volume: 28, Issue:11 Topics: Adenocarcinoma, Papillary; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2007
Antitumor and antivascular effects of AVE8062 in ovarian carcinoma. Cancer research, 2007, Oct-01, Volume: 67, Issue:19 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cell Growth Processes; Cell Line, Tumor; Docetaxel; Female; Fluorodeoxyglucose F18; G2 Phase; Humans; Mice; Mice, Nude; Neovascularization, Pathologic; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Serine; Taxoids; Xenograft Model Antitumor Assays	2007
Impact of FDG PET-CT imaging on the decision making in the biologic suspicion of ovarian carcinoma recurrence. Gynecologic oncology, 2008, Volume: 108, Issue:1 Topics: Adult; Aged; Aged, 80 and over; CA-125 Antigen; Decision Making; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Surveys and Questionnaires; Tomography, X-Ray Computed	2008
Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography--a prospective study. Gynecologic oncology, 2008, Volume: 108, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed	2008
A three-dimensional registration method for microUS/ microPET multimodality small-animal imaging. Ultrasonic imaging, 2007, Volume: 29, Issue:3 Topics: Algorithms; Animals; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Imaging, Three-Dimensional; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Ovarian Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Ultrasonography	2007
Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT. European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:8 Topics: Adult; Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Iopamidol; Male; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed	2008
Preoperative evaluation of pelvic masses with combined 18F-fluorodeoxyglucose positron emission tomography and computed tomography. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2008, Volume: 102, Issue:2 Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed	2008
Noninvasive tumor imaging with high-frequency ultrasound and microPET in small animals. Ultrasonic imaging, 2007, Volume: 29, Issue:4 Topics: Animals; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Image Processing, Computer-Assisted; Mice; Mice, Inbred C57BL; Models, Animal; Neoplasms, Experimental; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Ultrasonography	2007
Krukenberg tumor and lung metastases from colon carcinoma diagnosed with F-18 FDG PET. Clinical nuclear medicine, 1995, Volume: 20, Issue:5 Topics: Carcinoembryonic Antigen; Colorectal Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Krukenberg Tumor; Liver Neoplasms; Lung Neoplasms; Middle Aged; Ovarian Neoplasms; Tomography, Emission-Computed	1995
Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1995, Volume: 36, Issue:9 Topics: Cell Hypoxia; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Immunohistochemistry; Melanoma, Experimental; Monosaccharide Transport Proteins; Ovarian Neoplasms; Oxygen; Tumor Cells, Cultured	1995
Indium-111 OncoScint CR/OV and F-18 FDG in colorectal and ovarian carcinoma recurrences. Early observations. Clinical nuclear medicine, 1995, Volume: 20, Issue:3 Topics: Aged; Antibodies, Monoclonal; Colorectal Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Oligopeptides; Ovarian Neoplasms; Pentetic Acid; Tomography, Emission-Computed	1995
Whole-body positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose can detect recurrent ovarian carcinoma. Gynecologic oncology, 1993, Volume: 51, Issue:2 Topics: Adult; Aged; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Tomography, Emission-Computed	1993
Autoradiographic evaluation of the intra-tumoral distribution of 2-deoxy-D-glucose and monoclonal antibodies in xenografts of human ovarian adenocarcinoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1993, Volume: 34, Issue:1 Topics: Animals; Autoradiography; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Radioimmunodetection	1993
Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1993, Volume: 34, Issue:3 Topics: Adenocarcinoma; Cell Division; Deoxyglucose; DNA, Neoplasm; Female; Flow Cytometry; Fluorodeoxyglucose F18; Humans; In Vitro Techniques; Ovarian Neoplasms; Thymidine; Tritium; Tumor Cells, Cultured	1993
In vitro assessment of 2-fluoro-2-deoxy-D-glucose, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1993, Volume: 34, Issue:5 Topics: Adenocarcinoma; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; In Vitro Techniques; Methionine; Ovarian Neoplasms; Thymidine; Time Factors; Tomography, Emission-Computed; Tumor Cells, Cultured	1993
Effects of hypoxia on the uptake of tritiated thymidine, L-leucine, L-methionine and FDG in cultured cancer cells. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:3 Topics: Cell Hypoxia; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; In Vitro Techniques; Leucine; Melanoma; Methionine; Ovarian Neoplasms; Oxygen; Thymidine; Time Factors; Tomography, Emission-Computed; Tritium; Tumor Cells, Cultured	1996
Regression of advanced refractory ovarian cancer treated with iodine-131-labeled anti-CEA monoclonal antibody. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997, Volume: 38, Issue:2 Topics: Aged; Antibodies, Monoclonal; CA-125 Antigen; Carcinoembryonic Antigen; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Ovarian Neoplasms; Radioimmunotherapy; Remission Induction; Salvage Therapy; Tomography, Emission-Computed; Tomography, X-Ray Computed	1997
[Metabolic characterization of ovarian tumors with positron-emission tomography and F-18 fluorodeoxyglucose]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1997, Volume: 166, Issue:1 Topics: Adult; Aged; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed	1997
Effect of hyperglycemia on in vitro tumor uptake of tritiated FDG, thymidine, L-methionine and L-leucine. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997, Volume: 38, Issue:3 Topics: Adenocarcinoma; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hyperglycemia; Leucine; Methionine; Ovarian Neoplasms; Thymidine; Tomography, Emission-Computed; Tumor Cells, Cultured	1997
Comparison of three different methods for radiolabelling human activated T lymphocytes. European journal of nuclear medicine, 1997, Volume: 24, Issue:5 Topics: Cell Death; Cell Survival; Cells, Cultured; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Isotope Labeling; Lymphocyte Activation; Organometallic Compounds; Organotechnetium Compounds; Ovarian Neoplasms; Oximes; Oxyquinoline; T-Lymphocytes; Technetium Tc 99m Exametazime; Tumor Cells, Cultured	1997
[18F-fluorodeoxyglucose PET in ovarian carcinoma: methodology and preliminary results]. Nuklearmedizin. Nuclear medicine, 1997, Volume: 36, Issue:7 Topics: Adult; Aged; Cystadenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed	1997
Injection artifact on FDG PET imaging. Clinical nuclear medicine, 1998, Volume: 23, Issue:4 Topics: Adult; Artifacts; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Injections, Subcutaneous; Lymph Nodes; Lymphatic Metastasis; Ovarian Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed	1998
[Preoperative assessment of asymptomatic adnexal tumors by positron emission tomography and F 18 fluorodeoxyglucose]. Nuklearmedizin. Nuclear medicine, 1999, Volume: 38, Issue:4 Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Neoplasms, Adnexal and Skin Appendage; Ovarian Neoplasms; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed	1999
Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma. European radiology, 2000, Volume: 10, Issue:5 Topics: Adult; Aged; Carcinoma; Colonic Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laparotomy; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms; Prospective Studies; Radiography, Abdominal; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting	2000
[1959-1999: from serum markers to 18-FDG in oncology. The experience of the René-Huguenin Center]. Pathologie-biologie, 2000, Volume: 48, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; CA-125 Antigen; CA-19-9 Antigen; Carcinoembryonic Antigen; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Mucin-1; Neoplasm Proteins; Ovarian Neoplasms; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed	2000
[Detection of relapse in ovarian cancer by PET-FDG]. Revista espanola de medicina nuclear, 2001, Volume: 20, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cystadenocarcinoma, Serous; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Ovariectomy; Radionuclide Imaging; Radiopharmaceuticals; Splenic Neoplasms; Tomography, X-Ray Computed	2001
Clinical value of positron emission tomography with FDG for recurrent ovarian cancer. AJR. American journal of roentgenology, 2001, Volume: 176, Issue:6 Topics: Case-Control Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed	2001
Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomy. Gynecologic oncology, 2001, Volume: 82, Issue:1 Topics: Adenocarcinoma, Mucinous; Adenofibroma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carcinoma, Endometrioid; Female; Fluorodeoxyglucose F18; Humans; Laparotomy; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Radiopharmaceuticals; Reoperation; Sensitivity and Specificity; Tomography, Emission-Computed	2001
Diagnosis and localization of testosterone-producing ovarian tumors: imaging or biochemical evaluation. Gynecologic oncology, 2001, Volume: 83, Issue:3 Topics: Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Radiopharmaceuticals; Testosterone; Tomography, Emission-Computed	2001
The clinical application of a dual head gamma camera with coincidence detection in 20 women with suspected ovarian cancer. BJOG : an international journal of obstetrics and gynaecology, 2001, Volume: 108, Issue:12 Topics: Adult; Aged; Aged, 80 and over; CA-125 Antigen; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Middle Aged; Ovarian Neoplasms; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity	2001
Clinical value of positron emission tomography. AJR. American journal of roentgenology, 2002, Volume: 178, Issue:4 Topics: Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed	2002
The use of PET scanning in ovarian cancer. Gynecologic oncology, 2002, Volume: 85, Issue:2 Topics: Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed	2002
Asymptomatic adnexal masses: correlation of FDG PET and histopathologic findings. Radiology, 2002, Volume: 223, Issue:3 Topics: Adnexal Diseases; Adult; Aged; Aged, 80 and over; Confidence Intervals; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Ovarian Neoplasms; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Ultrasonography	2002
Determination of 2-fluoro-2-deoxy-D-glucose uptake and ATP level for evaluating drug effects in neoplastic cells. Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie, 1991, Volume: 191, Issue:1 Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Cell Survival; Deoxyglucose; Drug Screening Assays, Antitumor; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Leukemia L1210; Luminescent Measurements; Mice; Ovarian Neoplasms; Tumor Cells, Cultured	1991